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In the forensic science community, there is a vast need for tools to help assist investigations 
when standard DNA profiling methods are uninformative. Methods such as Forensic DNA 
Phenotyping (FDP) and proteomics aims to help this problem and provide aid in investigations 
when other methods have been exhausted. FDP is useful by providing physical appearance 
information, while proteomics allows for the examination of difficult samples, such as hair, to infer 
human identity and ancestry. To create a “biological eye witness” or develop informative 
probability of identity match statistics through proteomically inferred genetic profiles, it is 
necessary to constantly strive to improve these methods.  
 Currently, two developmentally validated FDP prediction assays, ‘HIrisPlex’ and 
‘HIrisplex-S’, are used on the capillary electrophoresis to develop a phenotypic prediction for eye, 
hair, and skin color based on 41 variants. Although highly useful, these assays are limited in their 
ability when used on the CE due to a 25 variant per assay cap. To overcome these limitations and 
expand the capacities of FDP, we successfully designed and validated a massive parallel 
sequencing (MPS) assay for use on both the ThermoFisher Scientific Ion Torrent and Illumina 
MiSeq systems that incorporates all HIrisPlex-S variants into one sensitive assay. With the 
migration of this assay to an MPS platform, we were able to create a semi-automated pipeline to 
extract SNP-specific sequencing data that can then be easily uploaded to the freely accessible 
online phenotypic prediction tool (found at https://hirisplex.erasmusmc.nl) and a mixture 
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deconvolution tool with built-in read count thresholds. Based on sequencing reads counts, this tool 
can be used to assist in the separation of difficult two-person mixture samples and outline the 
confidence in each genotype call. 
 In addition to FDP, proteomic methods, specifically in hair protein analysis, opens doors 
and possibilities for forensic investigations when standard DNA profiling methods come up short. 
Here, we analyzed 233 genetically variant peptides (GVPs) within hair-associated proteins and 
genes for 66 individuals. We assessed the proteomic methods ability to accurately infer and detect 
genotypes at each of the 233 SNPs and generated statistics for the probability of identity (PID). Of 
these markers, 32 passed all quality control and population genetics criteria and displayed an 
average PID of 3.58 x 10-4. A population genetics assessment was also conducted to identify any 
SNP that could be used to infer ancestry and/or identity. Providing this information is valuable for 
the future use of this set of markers for human identification in forensic science settings.  




CHAPTER 1. INTRODUCTION 
1.1 Purpose and Objectives 
The current gold standard of forensic DNA profiling is centered around short tandem repeats 
(STRs), however when this method fails to identify a possible contributor at a crime scene through 
DNA reference profile comparison or database search, alternative methods must be used to further 
the investigation. Forensic DNA Phenotyping (FDP), or the prediction of externally visible 
characteristics, extends current laboratory analyses and works to help identify an unknown 
perpetrator from trace amounts of DNA [1]. FDP is useful because of the technology’s ability to 
strengthen or disprove eye witness statements narrow down the suspect list through the ranking of 
the most probable appearance characteristics [2-5], and assign pigmentation to skeletal remains 
[6]. Another alternative method that can be used to further an investigation when standard STR 
profiling is not sufficient is through reverse proteomic methods of hair proteins. Proteomics brings 
the ability to analyze sample types that may not be suitable for standard forensic analyses (ie.hair 
shaft) [7] and shows potential for the generation of ancestry inference and probability of identity 
match statistics.  
Phenotypic prediction tools such as IrisPlex [2, 8], HIrisplex [3, 9], and HIrislex-S [4, 5] are 
beneficial in forensic casework, but currently these assays are limited in their scope and potential 
as they are run on capillary electrophoresis (CE) systems. Typically, CE systems are capped at 
approximately 25 DNA variants due to size and ability to adequately space fragments, in addition 
to the SNaPshot (ThermoFisher Scientific) chemistry’s reagent limitations. Due to the complex 
genetic nature of physical appearance traits, with each new trait would come a limitation of number 
of variants per assay. To advance the field of FDP, it is therefore vital to move to a platform that 
has the ability to analyze more DNA variants in a singular assay instead of generating additional 
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multiplex assays. Doing this on the CE would increase time, cost, and personnel needed to run the 
assays in order to expand phenotypic predictions. This limits the application of Forensic DNA 
Phenotyping and the progression of this intelligence approach with current technologies. Based 
upon this assessment, it is evident that a transition from CE to Massive Parallel Sequencing (MPS) 
technologies on benchtop sequencers (Illumina MiSeq, or ThermoFisher Scientific Ion Torrent) is 
the next logical and advantageous step for the future of Forensic DNA Phenotyping.
 Massive Parallel Sequencing (MPS), also referred to as Next-Generation Sequencing 
(NGS), follows some of the same basic principles of Capillary Electrophoresis (CE) by generation 
of fragment information. However, MPS can overcome common limitations set forth by capillary 
electrophoresis by increasing the multiplex capacity, requiring less input DNA, and generates 
output data that is far more informative [10]. Instruments like Illumina’s MiSeq and 
ThermoFisher’s Ion Torrent allow for numerous fragments of the genome to be sequenced 
simultaneously, resulting in a significantly lower cost than the previous methods of individually 
sequencing genomes [11] or Sangers singular fragments, while generating more data. The ability 
of this technique to produce results from hundreds to thousands of variants in a single run is an 
ideal tool for forensic researchers as it allows the capacity to expand the number of variants 
required for further developing FDP (in addition to ancestry estimation) without variant and trait 
limitations, to assist law enforcement investigations. In essence, the application of MPS 
technology to FDP assay development will revolutionize the DNA intelligence field for “biological 
witness” generation. 
 In forensic cases with samples containing low quantity, degraded, or non-nuclear DNA, 
common STR-typing and FDP methods may not be useful in producing genetic information that 
will aid in an investigation. A common type of sample found at crime scenes is hair due to its 
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ability to remain intact under a wide range of environmental conditions and situations. However, 
if a hair does not contain a root, and therefore lacks nuclear DNA, other methods of examination 
will be necessary for the identification of the individual who left the sample. Current forensic 
methods for the analysis of hair shaft samples are limited to the use of a microscopic examination 
or mitochondrial DNA (mtDNA) analysis, each with their own unique set of limitations [12, 13]. 
While the microscopic examination of hair provides vital information about the ancestral 
characteristics, structure, pigment, and size, it is not objective enough to match an individual to 
the sample with a high degree of certainty, thus creating a limitation on the evidentiary value of 
the examination in a court of law [14]. The most prevalent approach to the examination of a hair 
shaft is through mtDNA sequencing [15]. While this method does provide biogeographic 
information and limited identification through familial analysis, it requires careful analyst handling 
and is susceptible to environmental factors [13]. Mitochondrial DNA sequencing is also less 
discriminating than STR-typing, due to the nature of inheritance through the maternal lineage only. 
All maternally related individuals will inherit the same mitochondrial genome therefore limiting 
the capacity for identification. Due to these limitations in analysis methods, diving into other 
sources of forensic applications, such as proteomics, might be useful for biogeographical 
knowledge as well as human identification.   
 Due to its unique characteristics, proteomics can be used to differentiate protein-containing 
samples based on amino acid sequence changes [16]. Unlike DNA, which is the same in every cell 
of the organism, the proteome of each organ and/or tissue type is individual to the abundance and 
identity of its proteins [12]. Thus, the ability to identify protein sequence information can be used 
to distinguish genetically distinct individuals. In hair proteomics, technologies like mass 
spectrometry-based shotgun proteomic sequencing can be used to detect single amino acid 
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polymorphisms within a peptide. These single amino acid polymorphisms can then be used to infer 
the genotypes of non-synonymous single nucleotide polymorphism (nsSNP) alleles and provide a 
genetic profile for a hair sample of a particular individual [16]. 
 The first goal of this research was to design, validate, and assess the performance of the 
HIrisPlex-S system on the Illumina MiSeq, create tools to aid in interpretation of raw sequence 
data, and propose deconvolution steps to separate two-person mixture profiles. This manuscript 
has been submitted to Forensic Science International: Genetics, and can be seen in Chapter 2 of 
this thesis. The final goal of this research was to assess proteomic data for 99 individuals at 233 
different SNPs. Genotypes were inferred from the proteomic analysis data at each SNP, genotyping 
accuracy calculations were computed, and these SNPs were genetically evaluated with population 
data to generate a list of identity and ancestry informative markers.   
1.2 Biology of Pigment Formation 
To better understand the workings of pigmentation models, it is first necessary to provide 
some background information on the production of pigmentation through the melanin biochemical 
pathway. Melanin is a light absorbing biopolymer and is the source of human pigmentation. It is 
found in the melanocytes within the ocular (eye), follicular (hair), and epidermal (skin), causing 
the visible color in each [17]. The production of this pigmentation follows an intricate pathway 
with the outcome creating one of two types of melanin: Eumelanin or Pheomelanin. The 
production of eumelanin is responsible for darker colors, such as brownish and black pigment. 
Pheomelanin is responsible for lighter colors, like red-yellow pigment. The complex pigmentation 
pathway involves numerous different genes that code for many proteins such as receptors, 
transporters, and transcription factors [18, 19]. Genetically speaking, one of two pathways occur: 
1) MC1R is stimulated by an agonist called alpha-melanocyte-stimulating hormone (α-MSH) and 
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triggers the production of eumelanin or 2) the stimulation and binding of an antagonist called 
Agouti-Signaling-Protein (ASIP) will occur and cause a shift towards pheomelanin instead [18, 
19]. Ultimately, the visible spectrum of most pigmentation we see in hair, eye, and skin color is 
simply the ratio of pheomelanin to eumelanin. 
1.3 Hair Structure Formation 
The development of melanocytes follows a complex pathway. First, vacuoles arise and bud 
from the endoplasmic reticulum, forming premelanosomes. These premelanosomes then take in 
structural proteins and enzymes such as TYR and Keratin-Associated Proteins (KAP) [20]. From 
here, melanin synthesis begins resulting in melanosomes [19]. At this point, eumelanosomes only 
continue on with the binding of TYRP1 and DCT enzymes. Pheomelonosomes become transferred 
to the keratinocytes in an area of already formed melanocytes. This mode of transportation to the 














 As seen in Figure 1, the melanocytes reside in the proximal bulb of each hair and in the 
sebaceous gland. The melanocytes transfer the melanosomes to keratinocytes, which move up the 
shaft of the hair, and provide the visible pigment in the hair [21]. The melanocytes in the hair die 
at the end of the hair cycle, which lasts approximately 3-8 years and is composed of four different 
phases: Anagen, Catagen, Telogen, and Exogen. During the anagen phase, the hair is in a state of 
active growth. Melanogenesis of the hair only takes place during this phase. The catagen phase is 
the transition phase of the hair in which the follicle begins to separate from the dermal papilla. 
Melanogenesis does not occur during this phase. The telogen phase is the resting phase for the hair. 
This is where the follicle completely separates from the dermal papilla and melanogenesis is 
completely absent. Finally, the hair goes through exogen phase, which is when it will shed 
naturally. Melanogenesis does not occur during the exogen phase [19, 22, 23]. 
 Though pigmentation is the most noticeable hair-feature difference between individuals, 
the morphology of the hair is also very discriminating. In determining whether an individual has 
straight or curly hair, the instructions for the shape of the hair shaft begins in the hair follicle. Some 
of the major structural components of hair shaft fiber include hair keratin genes, keratin-associated 
proteins (KAP), and trichohyalin (TCHH) proteins [20, 24-26]. The TCHH gene is expressed in 
the developing inner root sheath of the hair follicle and provides instruction for the production of 
a protein called trichohyalin [25]. Trichohyalin binds to keratin intermediate filaments (KIF) to 
create cross-links that provide mechanical strength and structure to the hair shaft. Polymorphisms 
within the TCHH gene help to determine the shape and structure of the hair [26]. KAPs are located 
in the hair matrix around the keratin intermediate filaments and are coded by numerous multigene 
families that each consist of a single exon and no introns. They are one of the major components 
of the formation of the hair shaft through disulfide bond cross-linking with KIFs [20]. Studying 
19 
 
these major genes and proteins can provide vital information in the understanding of hair structure 
formation and therefore lead to improvements in phenotypic prediction models for hair type and 
proteomic methods for protein detection. 
1.4 The HIrisPlex-S Assay for Eye, Hair, and Skin Color Prediction for DNA 
Previous methods in Forensic DNA Phenotyping include the HIrisplex system [3], a novel 
and fully validated Forensic DNA Phenotyping tool that was released in 2014 by Walsh et al.  This 
tool allowed for the prediction of the externally visible characteristics of eye and hair color. Of the 
24 SNPS present in the HIrisPlex model, 6 of these SNPs were incorporated from a previously 
published model; the IrisPlex system [2] for the prediction of eye color. To expand on the amount 
of phenotypic knowledge gained from phenotyping, in 2017 Walsh et al. published the HIrisPlex-
S system [4] which has drastically improved the hair and eye color prediction while also adding 
on the additional trait of skin pigmentation. To develop this, 77 SNPs were assessed from 37 
genetic loci in 2025 globally dispersed individuals [5]. From this dataset, a novel prediction model 
was developed for a 5-scale system of skin color prediction based upon 36 SNPs from 16 genes. 
These five skin color categories received Area Under the Receiver Operating Curve (AUC) values 
of 0.83 for Very Pale, 0.76 for Pale, 0.78 for Intermediate, 0.98 for Dark, and 0.99 for Dark-Black 
skin color. This model was then combined with the previously established HIrisPlex system, 
creating the HIrisPlex-S system, a novel Forensic DNA Phenotyping tool for the prediction of eye, 
hair, and skin color [4, 5]. 
 Input data for the IrisPlex and HIrisPlex, is generated with one multiplex genotyping assay 
while the HIrisPlex-S input data is generated with two. Both multiplex assays, HIrisPlex and 
HIrisPlex-S, have successfully undergone forensic developmental validation testing. Through this 
validation, it was determined that both assays are capable of generating full genotypic profiles 
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from a minimum DNA input concentration of 63 pg. In totality, the HIrisPlex-S system is 
composed of 41 SNPs (Figure 2): 24 SNPs in the first assay (HIrisPlex) and 17 SNPs in the second 
assay. Genotype data of these 41 DNA variants can then be uploaded to the online web tool found 
at https://HIrisPlex.erasmusmc.nl/ to generate individual prediction probabilities for 3 eye color, 














Figure 2 A summary of a total of 41 variants covered in the three prediction models: IrisPlex eye (6 variants), 





1.5 Massive Parallel Sequencing 
Massive Parallel Sequencing (MPS) is an amplicon-based sequencing method. It can 
effectively address all of the short comings put forth by capillary electrophoresis by increasing the 
multiplex capacity, increasing the amount of sequencing data output, and decreasing the amount 
of input DNA required [10]. For massive parallel sequencing, libraries are generated after 
fragments, or amplicons, are isolated and then specific adapters are added for important use in 
downstream sequencing. These libraries are generated so that clonal amplification can take place 
on either a bead or flow cell. This allows for hundreds of thousands of copies or ‘clusters’ to be 
generated at once for sequencing [10]. There are multiple methods and platforms for massive 
parallel sequencing: semi-conductor sequencing (ThermoFisher Scientific IonTorrentTM), 
sequencing by synthesis (IlluminaTM), pyrosequencing (Roche 454TM), or sequencing by ligation 
(ThermoFisher Scientific SOLiD TM) [27-33]. The research conducted in this thesis will be 
focusing on the implementation of Forensic DNA Phenotyping on the Illumina Miseq FGx TM 
(Illumina, San Diego, CA, USA) and the ThermoFisher Scientific Ion Torrent TM (ThermoFisher 
Scientific, Waltham, MA, USA). 
The concept behind how Illumina MiSeq FGx TM MPS system functions holds several 
similarities to that of the CE in that a deoxyribonucleotide triphosphate (dNTP) is incorporated 
into the DNA strand through cycles of sequencing by synthesis that is facilitated by DNA 
polymerase. After this initial amplification, the PCR primers are tagged with individual barcodes 
for identification of the sample in downstream analyses. With more combinations of these 
individualizing barcodes, comes a greater ability to run a higher number of samples in one 
experiment. Once on the MiSeq, the pooled library containing the tagged fragments of DNA 
hybridizes to a flow cell through bridge PCR and amplifies, creating thousands of copies of the 
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sequences of interest. This is done simultaneously, creating “clusters” of millions of copies of 
DNA in parallel along the entire flow cell. The fluorescently labeled nucleotides incorporated 
within these “clusters” are imaged while being added through a process called “sequencing by 
synthesis”. This allows for identification by the machine after excitation from a laser generating 
sequence results that are then used for genome alignment and analysis [34].  
In contrast, Ion Torrent differs in the chemical methodology behind the machine’s ability 
to sequence the fragments of interest. The Ion Torrent utilizes the simple concept of a proton being 
released when a nucleotide is incorporated by the polymerase into the actual DNA molecule rather 
than the “sequencing by synthesis” method that the Illumina Miseq FGx utilizes. This sequencing 
is detected through a pH change in the surrounding region due to that release of the hydrogen. The 
Ion Torrent utilizes a semiconductor sequencing chip that incorporates hundreds of thousands of 
copies of the DNA. When the nucleotides are released to the chips those that are similar to the 
DNA molecule are incorporated and hydrogen ions are released into the solution resulting in pH 
changes in the corresponding well. This change in pH results in detection by the ion sensor which 
then converts that chemically obtained information to actual digital information. The voltage 
change occurs based on the type of nucleotides, for example if two bases are identical the voltage 
will be doubled that of a single nucleotide [35]. 
1.6 Proteomics 
 The proteome is defined as the complete set of proteins that are expressed or modified by 
an organism [12], biological system, or cell. Thus, proteomics is the study of proteomes and their 
functions. Similar to the genome, a proteome and protein expression is unique to each human being. 
Therefore, studying the specific sequences of proteins in a given sample can provide important 
information about the DNA sequence, and thus the expression in the individual [12]. Despite their 
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similarities, the study of the proteome is far more complex than that of the genome. Each individual 
has one nuclear genome; however, this singular genome contains genes that can produce several 
different protein variations due to alternative splicing and other modification events. This genetic 
variation can come in the form of single amino acid polymorphisms (SAAP) within a genetically 
variant peptide (GVP) [7, 13]. Technologies like mass spectrometry-based shotgun proteomic 
sequencing, which utilizes microcapillary columns to separate peptides by hydrophobicity and 
charge, can be used to detect these SAAPs within a peptide. These SAAPs can then be used to 
infer the genotypes of non-synonymous single nucleotide polymorphism (nsSNP) alleles 
regardless of the presence of a DNA template in the sample [16]. The genotypes of these separated 
nsSNPs can be combined to form a profile of genetic variation for an individual and potentially be 
used to acquire identifying and biogeographic information [7, 13].  
 Current studies in forensic proteomics focus on the detection of peptides in hair. Hair is 
composed primarily of keratin, which is a coiled-coil protein with a high degree of intermolecular 
disulphide and isopeptide covalent bonds [13]. These bonds are responsible for the robustness and 
physical flexibility of the hair. However, despite the strong and stable properties of the hair, it is a 
poor source of nuclear DNA due to apoptosis of the keratinocytes during hair shaft biogenesis and 
the natural weathering of hair throughout a lifetime. Alternatively, the hair does not lack in protein 
content with more than 300 proteins already being detected in the hair proteome [36], providing 
solid grounds to assess the usefulness of protein analyses in forensic and bioarcheological domains. 
 In a study by Lee et al., 343 hair shaft proteins were identified using two-dimensional 
liquid chromatography mass spectrometry. Of these 343 detected proteins, many were keratin or 
keratin associated proteins and in high abundance [36]. Another study tested hair shaft proteomes 
of four different ethnic groups and found significant variation in the abundance of specific keratins 
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between individuals within each ethnic group. The variation was smaller between each ethnic 
group and centered on keratin-associated proteins. A study by Milan et al. analyzed the differences 
in protein abundance and genetically variant peptides in hair throughout different parts of the body. 
They discovered that the protein levels vary as a function of genetic origin and the genetically 
variant peptides are more dependent on the individual [16]. In another study by Parker et al., 
researchers have explored the ability to identify an individual from single amino acid 
polymorphisms (SAAPs) in hair proteins. A total of 596 SNP genotypes were accurately imputed 
from these SAAPs, allowing for population (European) statistics to be computed for the generated 
allelic profiles. By using the product rule and known allelic frequencies in the population, a power 
of discrimination value of up to 1 in 12,500 was calculated, showing the ability to apply match 
probabilities to a hair sample [13]. These studies give insight on the usefulness of proteomic 
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Forensic DNA Phenotyping (FDP) provides the ability to predict externally visible 
characteristics from minute amounts of crime scene DNA, which can help find unknown 
perpetrators who are typically unidentifiable via conventional forensic DNA profiling. 
Fundamental human genetics research has led to a better understanding of the specific DNA 
variants responsible for physical appearance characteristics, particularly eye, hair, and skin color. 
Recently, we introduced the HIrisPlex-S system for the simultaneous prediction of eye, hair, and 
skin color based on 41 DNA variants generated from two forensically validated SNaPshot 
multiplex assays using capillary electrophoresis (CE). Here we introduce massively parallel 
sequencing (MPS) solutions for the HIrisPlex-S (HPS) system on two MPS platforms commonly 
used in forensics, Ion Torrent and MiSeq, that cover all 41 DNA variants in a single assay, 
respectively. Additionally we present the forensic developmental validation of the two HPS-MPS 
assays. The Ion Torrent MPS assay based on Ion AmpliSeq technology illustrated successful 
generation of full HIrisPlex-S genotypic profiles from 100 pg of input control DNA, while the 
MiSeq MPS assay based on an in-house design yielded complete profiles from 250 pg of input 
DNA. Assessing simulated forensic casework samples such as saliva, hair (bulb), blood, semen, 
and low quantity touch DNA, as well as artificially degraded DNA samples, concordance testing, 
and samples from numerous species, all illustrated the ability of both versions of the HIrisPlex-S 
MPS assay to produce results that motivate forensic applications. By also providing an integrated 
bioinformatics analysis pipeline, MPS data can now be analyzed and a file generated for upload to 
the publically accessible HIrisPlex online webtool (https://hirisplex.erasmusmc.nl). In addition, 
we updated the website to accept VCF input data for those with genome sequence data. We thus 
provide a user-friendly and semi-automated MPS workflow from DNA sample to individual eye, 
hair, and skin color prediction probabilities. Furthermore, we present a 2-person mixture separation 
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tool that not only assesses genotype reliability with regards genotyping confidence, but also 
provides the most fitting mixture scenario for both minor and major contributor, including profile 
separation. We envision this MPS implementation of the HIrisPlex-S system for eye, hair and skin 
color prediction from DNA as a starting point for further expanding MPS-based forensic DNA 
phenotyping. This may include the future addition of SNPs predictive for more externally visible 
characteristics, as well as SNPs for bio-geographic ancestry inference, provided the statistical 
framework for DNA prediction of these traits is in place.  
2.2 Introduction 
The standard approach to forensic DNA profiling for human identification purposes uses 
short tandem repeats (STRs); however, when this method fails to identify a known suspect to be 
the contributor of a crime scene trace, alternative methods must be available to further the forensic 
investigation. Forensic DNA Phenotyping (FDP) utilizes fundamental genetics knowledge in order 
to provide information on an unknown crime scene donor. Typically, FDP involves appearance 
traits, but inferring bio-geographic ancestry from DNA [1, 2] and estimating a person’s age from 
DNA [3, 4], are also considered under the wider umbrella of FDP. FDP represents an innovative 
investigation approach to forensic DNA application due to its ability to potentially strengthen or 
challenge eye-witness statements and provide biological witness information in cases without 
human eye-witnesses [5]. It is useful to narrow down suspect lists that are extensive in cases 
without known suspects [6, 7]. It has also been used to infer appearance predictions from skeletal 
remains [8], including those in the field of ancient DNA [9], making it useful in missing person 
identification cases that lack knowledge on the putative identity or on possible relatives. 
Recently, Walsh et al. [10] considerably improved knowledge on categorical skin color 
prediction from DNA, which has subsequently been used to extend the previously established 
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IrisPlex system for eye color and HIrisPlex system for hair color prediction from DNA [11-13] by 
developing the HIrisPlex-S system for eye, hair and skin color prediction from DNA [14]. Based 
upon current available statistical models, eye color prediction using the IrisPlex model [13] 
achieves prediction accuracies expressed as Area Under the Receiver Operating Curve (AUC) of 
0.94 for blue, 0.74 for intermediate, and 0.95 for brown eye color. Hair color prediction using the 
HIrisPlex model [11, 12] achieves an AUC performance metric of 0.93 for red, 0.81 for blond, 
0.74 for brown, and 0.86 for black, and skin color prediction using the HIrisPlex-S model [10] 
achieves an AUC performance metric of 0.83 for Very Pale, 0.76 for Pale, 0.78 for Intermediate, 
0.98 for Dark, and 0.99 for Dark to Black (based on full data model performance as measured 
March 2019 on https://hirisplex.erasmusmc.nl). In order to generate genetic data for input into the 
IrisPlex, HIrisPlex and HIrisPlex-S models, one (IrisPlex and HIrisPlex) or two (HIrisPlex-S) 
multiplex genotyping assays were previously established and successfully underwent forensic 
developmental validation testing [11, 13, 14]. The HIrisPlex-S system includes 41 DNA variants; 
24 variants targeted with the HIrisPlex assay [11, 12] and 17 additional variants targeted with a 
second assay [14]. Both multiplex assays are capable of generating full genotypic profiles from a 
minimum DNA input of 63 pg [11, 14]. Genotype data of these 41 DNA variants can then be 
uploaded to the easy-to-use web tool found at https://HIrisPlex.erasmusmc.nl/ to generate 
individual prediction probabilities for 3 eye color, 4 hair color, and 5 skin color categories [14].  
 While the previously developed IrisPlex, HIrisPlex and HIrisPlex-S multiplex assays have 
been demonstrated to be sensitive, robust and reliable, and able to cope with the specific 
requirements of forensic DNA analysis in dealing with low quantity and quality DNA [10-15], the 
underlying single base primer extension (SNaPshot) and capillary electrophoresis (CE) 
technologies have limitations. Due to the chemistry and fragment sizing used, the multiplex 
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capacity of a SNaPshot genotyping assay is typically limited to approximately 25 DNA variants 
per single assay. As a consequence, if more DNA variants need to be analyzed for a specific 
forensic purpose, for example, the 41 from the HIrisPlex-S system, more multiplex assays, such 
as two in the case of HIrisPlex-S, have to be developed, validated and finally applied. This leads 
to the consumption of additional evidence DNA that in some cases may not be available, also given 
that FDP is typically performed subsequently to DNA-consuming conventional forensic STR 
profiling. Moreover, running multiple assays increases the time, cost, and efforts needed. In 
addition, deconvolution or separation of DNA mixture profiles generated by several contributors 
is challenging, if not impossible, with SNP assays using SNaPshot and CE, because of the semi-
quantitative nature of these technologies. Lastly, the limited multiplex capacity of the SNaPshot-
CE approach means it cannot easily be expanded to include new DNA variants from developments 
in the field for additional appearance traits for which statistical prediction models have already 
been developed, such as hair structure and hair loss [16-19] for example, as well as ancestry-
informative SNPs. Therefore it is apparent that a transition towards targeted massively parallel 
sequencing (MPS) solutions is required for FDP purposes in order to take advantage of the 
increasing knowledge that improved appearance (and ancestry) genetics provides.  
Targeted MPS technologies are characterized by a dramatic increase in multiplexing capacity 
relative to all DNA technologies previously used in forensic DNA analysis including SNaPshot-
CE. The technological transition from CE to MPS has started in the forensic field, mostly for STRs, 
but also for SNP sequencing (e.g. using ThermoFisher Scientific Precision ID Identity Panel [20], 
and ThermoFisher Scientific Precision ID whole mtDNA genome [21], respectively. In addition, 
the multi-purpose ForenSeq™ DNA Signature Prep [22], developed by Illumina (now Verogen) 
includes the HIrisPlex DNA markers. Moreover, non-commercial developments have 
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demonstrated that several hundreds of SNPs can be simultaneously analyzed via single targeted 
MPS assays, as demonstrated for Y-SNPs [7] and the entire mitogenome [23]. Here we describe 
the development and forensic validation of MPS solutions for the HIrisPlex-S (HPS) system for 
the two MPS platforms most commonly used in forensic genetics; Ion Torrent (ThermoFisher 
Scientific) and MiSeq (Illumina). Parallel assessments were made because of the differing 
performance metrics, as well as the different underlying sequencing principles and methodologies 
in each MPS platforms; sequencing by synthesis for MiSeq and semi-conductor sequencing for 
Ion Torrent.  Although there is the potential to run identical MPS assays on both platforms, for the 
present study, the applied MiSeq assay design reflected an in-house alternative to the commercial 
AmpliSeq assay design used for Ion Torrent.  
2.3 Materials and Methods 
Study samples were collected in compliance with Indiana University IRB#1409306349 and 
included informed consent for all individuals. Test samples were made up of single and multiple 
source samples, including simulated casework (saliva, blood, semen, hair (including bulb), vaginal 
swabs and touched items) and non-human samples. Supplementary Table 1 (Appendix A) 
describes the 96 samples used for this forensic developmental validation, their DNA input 
concentration for sequencing, and eye, hair and skin color phenotypes. DNA was extracted using 
an in-house salting out protocol (unpublished). Sample DNA concentrations were determined by 
qPCR via InnoQuant Human DNA Quantification and Degradation Assessment Kit [24] and/or 
the Quantifiler Trio DNA Quantification kit (ThermoFisher Scientific (TFS), Waltham, MA, USA) 
and plated at the US site. Results from the 96 samples were used to generate data to test the 
performance of two MPS assays, one in-house designed for the Illumina MiSeq platform by the 
US site, and a separate Ion AmpliSeq assay designed by the Rotterdam side together with 
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Jagiellonion University and TFS for use on the Ion Torrent platform. Both MPS assays underwent 
forensic developmental validation testing using these samples. In addition, all genotypes generated 
through amplicon sequencing were also confirmed through CE-SBE genotyping using previously 
published and developmentally validated HIrisPlex and HIrisPlex-S SNaPshot assays[11, 14].  
 
HIrisPlex-S Assay design for Massive Parallel Sequencing using MiSeq (HPS-MPS-MiSeq) 
The custom protocol used to generate the assay design for the Illumina MiSeq Sequencer 
was based on an in-house design using modifications of the protocol published by Bronner et al. 
[25]. Each of the primer pairs were designed to isolate between 100 to 300bp around the variant 
of interest using a proposed optimal primer pair from the free web-based design tool Primer3Plus 
[26]. These primers also included specific adapter sequences, therefore allowing the fragments or 
amplicons to adhere to the lawn found on the Illumina MiSeq flow cell. The selection of the 
primers used in this design was checked by using the program Bisearch [27] to ensure that specific 
unique amplicons were generated. Lastly, the program AutoDimer [28] was used to check for 
primer-dimers and/or primer to primer interactions (including potential interactions with adapter 
sequences) within the multiplex. The hg19 position of the 41 variants used in the HIrisPlex-S 
system, including the primer pair designs with incorporated adapter sequences for the Illumina 





Table 1 Information on the 41 DNA variants used in the HirisPlex-S system, including the primer pair designs with incorporated adapter sequences used for the HPS-MPS-MiSeq protocol, and their concentration 
SNP  Gene  Chromosome  Position Ref Allele 
Alt 















AGAGACAGTCAGAGATGGACACCTCCAG 184 0.7 








AGAGACAGTCCAGCAGGAGGATGACG 225 0.7 
rs885479 MC1R 16 89986154 G A 
rs1805007 MC1R 16 89986117 C T 
rs1805008 MC1R 16 89986144 C T 
rs201326893 MC1R 16 89986122 C A 
rs1110400 MC1R 16 89986130 T C 








AGACAGAGCGTGCTGAAGACGACAC 214 0.7 rs1805005 MC1R 16 89985844 G T 
rs1805006 MC1R 16 89985918 C A 







AGACAGCACCTCCTTGAGCGTCCTG 173 0.5 












Table 1 continued 







GAGACAGCGAAAGAGGAGTCGAGGTTG 195 0.4 





AGAGACAGGGAGCCAAGGGCATGTTACT 185 0.6 




AGAGACAGGTGTTCTTACCCCCTGTGGA 207 0.4 




GAGACAGGCTTCGTCATATGGCTAAACCT 193 0.5 




GAGACAGGCTTCATGGGCAAAATCAAT 191 0.55 







GACAGCGATGAGACAGAGCATGATGA 191 0.35 




GAGACAGTTCACCTCGATGACGATGAT 217 0.35 







GAGACAGGGCCCCTGATGATGATAGC 163 0.45 




GAGACAGCATTGCTTTTCAGCCCACAC 203 0.35 




AGACAGGACCCTGTGTGAGACCCAGT 192 0.4 




GAGACAGGGGAAGGTGAATGATAACACG 191 0.6 









Table 1 continued 




GAGACAGACAGGAATGGCAGCTTTGAG 166 0.2 







GAGACAGGGGACAAACGAATTGAGGAA 212 0.65 




GACAGCGTCATGACTAGAAAAACACCAA 143 0.4 







AGACAGCTGATTCAGGTCTGCTGTCACT 179 0.25 




AGACAGCTCTTTGGACCCATCACCTC 196 0.4 







GAGACAGGAATTGCACCTGTAGCTCCAT 217 0.4 







GAGACAGACACCAGGCAGCCTACAGTC 204 0.4 







AGACAGCAGCAATTCAAAACGTGCAT 184 0.4 







AGACAGGGTGCATTGGCTTCTGGATA 167 0.4 







GACAGGGAAAATATGTTAGGGTTGATGG 212 0.8 










Table 1 continued 




ACAGAACCCGAAGGAAGAGTGAAAA 130 0.25 







AGAAATGGAGATATAGAATTCACACAACA 188 0.8 




AGAGACAGAGGAGAAAGCTGCAGATCCA 179 0.45 







AGAGACAGACAATCCTGGGAGGTACACG 204 0.35 







AGAGACAGCATCAAAGGCAGACCTCTCG 211 0.8 




GAGACAGTTGCAACAGGAGGGTCTAGG 191 0.3 
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Due to the temperature range needed for the incorporation of multiple primers in this 
multiplex, a touchdown PCR program was applied for the first PCR of the assay, using an 
Eppendorf Mastercycler Nexus SX1 and cycles: 1) 94 °C for 10 minutes, 2) 14 cycles of 94 °C for 
20 seconds and 64 °C (with temperature decreases of -0.6 °C per each additional cycle) for 1 
minute each (touchdown range of 64 °C – 55.6 °C), 3) 20 cycles of 94 °C for 20 seconds and 57 °C 
for 1 minute, and 68 °C for 30 seconds, 4) 72 °C for 3 minutes, 5) hold at 10ºC. PCR amplification 
was performed in a single multiplex PCR assay with a 10 µL total volume containing 1 µL genomic 
DNA (varying concentrations), primers (see Table 1), 1X PCR gold buffer (Applied Biosystems), 
2.5 mM MgCl2 (Applied Biosystems), 220 µM of each dNTP (TFS) and 2 U AmpliTaq Gold DNA 
polymerase (Applied Biosystems). Bead clean-up was then performed using a ratio of 9 µL of 
AmPure XP (Beckman Coulter, Indianapolis, IN, USA) beads to 5 µL PCR product. After mixing 
thoroughly, the samples were incubated for 5 minutes to allow for binding of the beads to the DNA, 
then the samples were placed on a magnetic stand for 5 minutes. All but 5 µL of the supernatant 
was removed and discarded while on the stand and then washed with 200 µL of 70% Ethanol. The 
ethanol was removed in the same fashion and then the wash was repeated after 30s. The samples 
were air dried for 2-5 minutes, re-suspended in 20 µL of purified water, and mixed thoroughly. 
After a 2-minute incubation, the samples were placed on a magnetic stand for 1 minute, and then 
transferred to a new plate.  
The second round of PCR amplification was then performed to add index sequences to 
each sample as a unique identifier in order to de-multiplex (separate) each individual’s FASTQ 
files after sequencing. For each well 5 µL of KAPA master mix (KAPA Biosystems, Wilmington, 
MA), 1 µL of each Nextera index (both forward and reverse to total 2 µL), 2 µL of H20, and 1 µL 
of DNA were added to each well. The samples were placed on the thermocycler with the following 
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protocol: 1) 98 °C for 2 minutes, 2) 12 cycles of 98 °C for 30 seconds and 72 °C for 30 seconds, 
3) 72 °C for 5 minutes, 4) hold at 15ºC. Another bead clean up, as described above, followed this 
indexing reaction. 
 To successfully sequence the 96 samples in one sequencing run, the products were pooled, 
diluted and quantified as follows to complete the library preparation. 5 µL of each sample was 
pooled and then quantified using the Qubit Fluorometer (TFS) following the standard 
manufacturer’s guidelines. An in-house dilution calculator was used then to calculate an accurate 
dilution to a 2nM overall library concentration. Denaturing the library used 5 µL of 0.2 N NaOH 
to 5 µL of the 2nM library. Tubes were spun down, then incubated for 5 minutes at room 
temperature. The library was diluted to 10pM with 990 µL of Hybridization Buffer (Illumina, San 
Diego, CA) as provided with the Illumina Nextera XT Version 2 Kit (Illumina, San Diego, CA) 
and further diluted to 8pM using 480 µL of library and 120 µL of Hybridization Buffer with pulse 
vortexing. For optimal sequencing results, a PhiX control was spiked in at 20% to standardize the 
run. Preparation of the controls was as follows: 5 µL of the 4nM PhiX library was added to 5 µL 
of 0.2 N NaOH. The control was then vortexed, spun down, and incubated for 5 minutes. A further 
dilution was performed using 10 µL of PhiX Library and 990 µL of Hybridization Buffer to a final 
concentration of 20pM PhiX library. The final dilution to 12.5 pM was then performed using 375 
µL of the previously diluted PhiX library and 225 µL of Hybridization Buffer. The last step before 
adding the samples to the MiSeq cartridge was to spike in the 20% PhiX control to the custom 
library (120 µL PhiX and 480 µL of the library). 600 µL of the combined library and control was 
then loaded into the MiSeq cartridge. The Illumina MiSeq v2 Reagent Kit cartridge was then run 
on ‘Research Use Only’ Mode through the Nextera XT sequencing. The MiSeq Reporter software 
(Illumina, San Diego, CA) de-multiplexes the samples by utilizing the uploaded sample sheet to 
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assign sample names through correlation with the appropriate indices. Sequences are then exported 
as two paired-end FASTQ files, titled with their respective sample name for use in downstream 
analyses.   
 
HIrisPlex-S Assay design for Massive Parallel Sequencing using Ion Torrent (HPS-MPS-ION) 
The Ampliseq primers were designed and tested for good performance by TFS, Erasmus 
MC Rotterdam and Jagiellonian University. Ion AmpliSeq™ Library Kit 2.0 chemistry (TFS) was 
used following the manufacturer’s guidelines and using Ion Xpress™ Barcode Adapters (TFS). 
Twenty cycles of amplification as well as the incubation steps were performed on a Veriti™ 96-
Well Thermal Cycler (TFS), the libraries were quantified using the TaqMan™ Library 
Quantitation Kit (TFS) on a CFX96 Touch™ Real-Time PCR machine (Bio-Rad, Hercules, CA, 
USA), then normalized and pooled accordingly. Template preparation was performed using the 
Ion PGM™ Hi-Q™ View OT2 Kit (TFS) following the manufacturer’s guidelines. Sequencing of 
48 samples per chip was performed on Ion 318™ Chip Kit v2 BC (TFS) using Ion PGM™ Hi-
Q™ View Sequencing Kit (TFS) following the manufacturer’s guidelines. The Ion Personal 
Genome Machine™ (PGM™) System (TFS) was used for simultaneous sequencing of all Ion 
Torrent applications of this study (apart from Site 4, which used the Ion S5 system and 530 chip). 
Torrent Suite version 5.2.2 was used for initial data processing and base calling, the resulting 
FASTQ files were exported and used for downstream pipeline analysis.  
 
Sensitivity & sequence coverage  
The sensitivity of both MPS assays was evaluated to determine the minimum input needed 
to obtain a complete 41-SNP HPS profile. Two commercial control DNA samples, 9947A 
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(OriGene, Rockville, MD, USA) and 9948 (OriGene, Rockville, MD, USA), were used to prepare 
serial dilutions to concentrations of 5pg, 10pg, 25pg, 50pg, 100pg, 250pg, 500pg, and 1ng. For the 
MiSeq assessment, each concentration was performed in duplicate for both controls. These high 
quality control samples were used to assess each HPS amplicons’ accuracy and sequencing 
coverage at differing concentrations for each assay design and were used to set thresholds for 
genotype calling used in the Threshold & Mixture Tool (Supplementary Table 2 [Appendix B]). 
For HPS-MPS-MiSeq calls, these threshold values were calculated from two control samples run 
in duplicate at 100pg and 50pg for a total of 4 samples at each concentration (see Supplementary 
Table 5 [Appendix E] for more details). For HPS-MPS-ION, these threshold values were 
calculated from two control samples run at 100pg and 50pg for a total of 2 samples at each 
concentration. Percent sequencing error of the controls was calculated as the number of incorrect 
calls at that variant site within the amplicon as determined by sequencing quality and the BCFtools 
mpileup and call algorithm. The allele depth DP4 classification was assessed from the VCF file 
and is defined as the number of: 1) forward ref alleles; 2) reverse ref; 3) forward alt; 4) reverse alt 
alleles, used in variant calling at a site. For example, if an expected AA genotype within an 
individual displayed sequence reads of an allele other than A at that site (or no A allele at all), this 
was used to calculate that sites % error. In addition, an assessment of the genotype calls 
(homozygote and heterozygote) and coverage of each HPS variant site with a 500 pg DNA input 
from multiple individuals (n=8), generated by the HPS-MPS pipeline, was also evaluated, 




Simulated casework, stability testing and mixture assessment  
For the simulated casework samples, samples were manufactured with dried and UV 
degraded blood, dried and UV degraded saliva, wet saliva, touch DNA, hair, vaginal swab, and 
vaginal swab mixture with semen (see Supplementary Table 1 [Appendix A]). These samples were 
extracted with the salting out method and quantified using the Quantifiler Trio DNA Quantification 
kit (TFS) to assess quantity and quality of the samples prior to library preparation.  
DNA from one individual measured at 500pg DNA was then exposed to UV light for time 
intervals of 0, 5, 10, and 20 minutes using the CL-1000 Ultraviolet Crosslinker (Ultra-Violet 
Products Ltd, Upland, CA, USA) at a strength of 50 J/cm2 in order to test the robustness of each 
assay to analyze Degraded DNA.  
Two person mixtures were tested in ratios of 1:1, 1:2, 1:5, and 1:10 in duplicate. To ensure 
a mixture of DNA variants were present in the sample, there were two sets of 2-person mixtures 
(number of individuals = 4) were set up to contribute to the sample mixtures that had differing eye, 
hair, and skin colors (see Supplementary Table 1 [Appendix A] for more details). The 2-person 
mixture deconvolution tool (see Supplementary Table 2 [Appendix B]) was designed using a 2-
person ratio calculation (Minor:Major ratio out of 1 e.g.  a 1:1 ratio is ½ and was input as 0.5) in 
addition to using knowledge of heterozygote read count ranges as observed from the 500 pg variant 
coverage samples from 8 individuals (performed in duplicate). The calculator displays read counts 
(+/- sd) for all 2-person mixture scenarios using the allele read counts input from the HPS-MPS 
pipeline for that particular mixture sample. A guide on how to use the tool is outlined in 




Species specificity and concordance testing 
Species specificity testing is necessary in order to determine the possible contributors of a 
biological sample, as crime scenes can be prone to contamination from non-human sources. 
Therefore, each assay was tested for human specificity against samples of cat, primate, dog, mouse, 
and pig DNA at 1ng input. All non-human samples were extracted through an in-house extraction 
method, apart from the chimp sample obtained from a collaborator (Dr. Brenda Bradley - George 
Washington University). 
Concordance testing ensures that the two assays perform consistently among different 
laboratories and personnel with varying experiences. To do this, a concordance plate (sample n=16 
subset) was generated from the 96-sample set used in this study by the US (Illumina MiSeq 
platform) and Netherlands Erasmus MC (Ion Torrent platform) sites. This concordance plate was 
sent to five external European collaborators. Information on the samples and the sites 
instrumentation can be found in Supplementary Table 3 (Appendix C). Users were asked to 
indicate if the sample was a mixture or a single source. If a single source was indicated, users were 
also asked to provide a final predicted profile. 
 
Genotype calling and webtool upload  
For consistency, a pipeline was designed so that both platforms were assessed using the 
same algorithms to generate the 41 genotype calls needed for prediction model input to the web-
based HIrisPlex-S prediction tool. See Figure 3 (Figure 1 in manuscript) for pipeline overview. 
Raw data was aligned to the hg19 human reference sequences for all amplicons using the mem 
algorithm within BWA (http://bio-bwa.sourceforge.net/) [29]. The sequence alignment/map (SAM) 
file was converted and sorted using SAMtools into a BAM file [30] and read groups added via 
Picard Tools (https://github.com/broadinstitute/picard). Variant calling was performed by 
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BCFtools (http://github.com/samtools/bcftools) using mpileup (set to a depth read of 8000), call 
(using the multi-allelic caller for all sites –m -M) and query commands for SNP extraction. For 
more information of how BCFtools multiallelic caller performs during genotype calling, please 
see the manual found at https://samtools.github.io/bcftools/. Finally, the Java applet VarScan [31] 
was used to detect the presence or absence of the INDEL rs796296176 (variant 1 of HIrisPlex). 
The R program [32] was used to generate the upload file required for usage on the HIrisPlex 
webtool site. The pipeline can generate HPS-MPS results for up to 96 samples at a time; however, 
this script is customizable to include more samples if desired. In addition, the environment needed 
to run this pipeline has also been packaged into a Docker (https://www.docker.com) container 
image, which can be accessed via the Docker Hub under suswalsh/hpsmps. All information 
regarding the pipeline and a guide on how to use it can be found in Supplementary Material 2 
(Appendix L). 
2.4 Results and Discussion 
MPS assay design and analysis pipeline 
Two versions of the HIrisPlex-S MPS-based lab tool for the two MPS platforms commonly 
used in forensic genetics were designed and assessed in this study, HPS-MPS-MiSeq and HPS-
MPS-ION, to target the 41 DNA variants included in the HIrisPlex-S system via 34 amplicons. 
Care was taken to design the amplicons to be as short as possible to optimize analysis of low 
quality DNA, commonly encountered in forensic DNA testing. For HPS-MPS-MiSeq, the size of 
the 34 amplicons ranged between 130 and 225 bp in length and the average length across amplicons 
was 124 bp. For HPS-MPS-ION, the insert size ranged between 44 and 113 bp and the average 
insert size across amplicons was 71 bp.  
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The HPS-MPS analysis pipeline was designed to be user-friendly and semi-automated to 
ease the entire process from DNA sample to the sample donors eye, hair, and skin color prediction 
probabilities, estimated via the HIrisPlex webtool (https://HIrisPlex.erasmusmc.nl/). In its current 
version, the analysis pipeline can run 96 samples at a time and simply requires the sample name 
and raw FASTQ sequence files generated from any sequencer, as per the instructions found in 
Supplementary Material 2 (Appendix L), but customization towards more samples is possible by 
the user. As part of the HPS-MPS analysis pipeline, the sequence files are aligned to the human 
reference sequence hg19 (obtained from ftp://hgdownload.soe.ucsc.edu/goldenPath/hg19) and 
genotypes are extracted at the 41 DNA variant sites using a location text file. The process and tools 
used are illustrated in Figure 3 (Figure 1 in manuscript) below. 
Figure 3 (Figure 1 in manuscript) Illustrative example of the HIrisPlex-S MPS pipeline used to assess and call 
genotypic information from raw HPS-MPS sequencing data and file generation for online webtool input using an 
automated set of scripts and programs 
 
A more thorough guide is provided in Supplementary Material 2 (Appendix L) that 
explains the entire process including the computer set up needed to run these analyses. This 
pipeline can be run on all computer platforms; it is primarily designed (scripts) for use on a linux 
platform, however due to the use of the Docker container and its internal linux environment, it can 
be used on any platform (Mac OS, and Windows PC). An organized folder system is created for 
each sample to easily find sorted bam and vcf files. A table file folder contains all result files with 
46 
 
r genotype calls and read counts and finally a result folder contains all 96 samples in one upload 
file for use on the webtool prediction site. Notably, the HPS-MPS analysis pipeline is designed to 
work with any raw sequencing data including the HPS markers, not only the data generated from 
these targeted MPS assays. Thus, the pipeline can work with other targeted MPS data as well as 
with whole genome or capture sequencing data (once the HPS variant’s region is covered), as it 
flips strands into the correct orientation for all 41 DNA variants for upload to the HIrisPlex-S 
webtool. For all assessments discussed below, both MPS assays utilized the same HPS-MPS 
analysis pipeline to generate the genotype calls and read counts. 
 
Sensitivity testing and coverage consistency 
In order to test the sensitivity of the two HPS-MPS assays on their respective MPS 
platforms, control DNA samples 9947A and 9948 were sequenced at DNA input concentrations 
of 5pg, 10pg, 25pg, 50pg, 100pg, 250pg, 500pg, and 1ng. For HPS-MPS-MiSeq, complete HPS 
profiles were observed for the 500pg and 250pg samples and for 3 of the 4 100pg samples (Figure 
4 [Figure 2 in manuscript]). In the 100pg 9947A sample showing incomplete profiling, 12 
amplicons were affected i.e., rs12203592 (IRF4 amplicon), rs2378249 (PIGU amplicon), 
rs1393350 (TYR amplicon), rs10756819 (BNC2 amplicon), rs2238289 (HERC2 amplicon 2), 
rs1129038 (HERC2 amplicon 4), rs17128291 (SLC24A4 amplicon), rs1126809 (MC1R amplicon 
5), rs3212355 (MC1R amplicon 6), rs1426654 (SLC24A5 amplicon), rs6059655 (RALY amplicon), 
and rs8051733 (DEF8 amplicon). At 50 pg input, drop out was seen at less loci, which included 
rs17128291 (SLC24A4 amplicon) and rs6059655 (RALY amplicon) for sample 9947A and 
rs4959270 (EXOC2 amplicon), rs12203592 (IRF4 amplicon), rs12821256 (KITLG amplicon), and 
rs10756819 (BNC2 amplicon) for sample 9948. Therefore based on these results, the sensitivity 
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threshold for the HPS-MPS-MiSeq assay is set to 250 pg. Further sensitivity testing using more 
DNA samples in varying concentrations shall be carried-out to clarify if drop-outs are consistently 
observed DNA inputs of 100 pg and below with this assay and platform, or not.  
The same DNA samples in the same dilutions were tested with the HPS-MPS-ION assay, 
albeit not in duplicate. As seen in Figure 4 (Figure 2 in manuscript) below, complete HPS profiles 
were observed at 100pg DNA input in all samples tested. Drop-out started to occur at 50 pg DNA 
input, which affected one amplicon with one HPS DNA variant (rs683 in the TYRP1 amplicon). 
At 25 pg input DNA, more drop out occurred at rs12203592 (IRF4 amplicon) and rs2238289 
(HERC2 amplicon 2) for sample 9948, and rs2238289 (HERC2 amplicon 2) and rs6059655 (RALY 















Figure 4 (Figure 2 in manuscript) Sensitivity testing of both the HIrisPlex-S MPS tool with the HPS-MPS-MiSeq 
and the HPS-MPS-ION assays using control DNA samples 9947A and 9948 shown for the 34 amplicons used to 
sequence the 41 HIrisPlex-S DNA variants. Blue bars indicate correct calls in all samples analyzed at that DNA 
concentration, orange bars indicate an incorrect call was made in one sample at that concentration.  
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Supplementary Table 4 (Appendix D) provides a further breakdown of amplicon drop-out 
and sequencing error per HPS SNP variant per assay and platform-based on the two control DNA 
samples 9948 and 9947A at concentrations ranging from 250 pg – 25 pg DNA input. As an 
example, approx. 50% error indicates at least one sample had complete dropout for that DNA 
variant, closer to 100% indicates drop out for all samples at that site, and lastly approx. 25% would 
indicate at least one allele from that variant had dropped out for that sample. Apart from drop out 
of certain alleles at DNA input levels below the identified sensitivity threshold, percent error was 
broadly consistent between both assays and platforms. However, the HPS-MPS-ION assay had 
lower sequencing error per DNA variant than the HPS-MPS-MiSeq assay did e.g. 0.07% HPS-
MPS-ION and 0.32% HPS-MPS-MiSeq at 250pg DNA input after pipeline application. 
Overall, as seen in Figure 4 (Figure 2 in manuscript), the HPS-MPS-ION achieved more 
evenly distributed sequencing coverage across the amplicons and across DNA input concentrations 
compared to HPS-MPS-MiSeq analyses. However, the HPS-MPS-MiSeq assay displayed 
considerably higher read coverages (up to 3 times the reads at some amplicons) than the HPS-
MPS-ION, where some amplicons had less than 100 reads, even at 250 pg DNA input. Figure 4 
(Figure 2 in manuscript) also includes the genotype profiles consistently generated by both HPS-
MPS assays (as well as the HPS SBE-CE assays) of control DNA samples 9947A, 9948, and 
2800M (Promega, Madison, WI). 2800M was not assessed in this sensitivity study. 
One of the reasons for the differences in performance observed with the two HPS-MPS 
assays may be due to the unequal number of DNA samples included in the respective singular 
sequencing runs. For this validation testing, 96 samples were sequenced from one cartridge for 
HPS-MPS-MiSeq, while for HPS-MPS-ION they were sequenced with two chips each running up 
to 48 samples in parallel. Reducing the number of samples in the MiSeq run may increase the 
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sensitivity and thus the likelihood of recovering a full genotypic profile at a lower DNA input 
amount than the sensitivity threshold obtained here indicates.  
In an effort to measure the occurrence of drop out in a low input DNA sample and to 
provide a threshold for users of both HPS MPS assays, read counts were also assessed for all 
samples used in the sensitivity testing on whether the genotype was called correctly or if drop out 
occurred at that locus. Supplementary Table 5 (Appendix E) provides a confidence read count 
value for all 41 HPS sites for both MPS assays based on information from this validation. These 
confidence values reported average read counts as well as minimum read count values of the 100 
pg DNA input samples (HPS-MPS-MiSeq N=4, HPS-MPS-ION N=2) used in sensitivity testing 
in which genotypes were accurately called by the genotyping pipeline. Supplementary Table 5 
(Appendix E) also provides a recommended read count genotype confidence threshold average 
and minimum read count as a threshold set to ensure genotypes were called correctly between the 
50 to 100 pg DNA input levels (based on 50 pg input DNA sensitivity samples HPS-MPS-MiSeq 
N=4, HPS-MPS-ION N=2). However, this is less than the obtained sensitivity threshold of both 
assays (which represents the minimal DNA input to achieve a result at all 41 DNA variants), so 
caution is recommended with these read count thresholds. If the read count threshold is not passed 
at the 50 pg minimum read count threshold, it is advised not to trust this genotype call and it should 
be reported as NA for upload to the prediction webtool. In order to semi-automate this process of 
threshold passes in a user-friendly manner, these read counts have been incorporated into the 
Threshold and Mixture Tool found in Supplementary Table 2 (Appendix B). A singular sample 
read count genotype confidence threshold for calls is not possible to determine for both HPS-MPS 
assays due to differing performance of the primers during the entire sequencing process and it is 
recommended to follow the thresholds per DNA variant instead as shown in these tables for both 
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workflows. Additional runs of 100 and 50 pg DNA input control and non-control samples may 
help further refine these read count threshold indicators, and these values can therefore be edited 
in the tool if the user wanted to define a more stringent threshold level. A guide on how to use this 
tool can be found in Supplementary Material 1 (Appendix K). 
To assess coverage consistency of read counts for homozygote and heterozygote alleles for 
both HPS-MPS assays, several pre-selected individuals (N=8) with varying phenotype and 
genotype profiles, were analyzed in duplicate for a total DNA input of 500 pg per sample. Average 
read counts per allele were assessed for homozygote and heterozygote genotype calls using the 
















Figure 5 (Figure 3 in manuscript) Homozygote and heterozygote average peak heights from HIrisPlex-S MPS 





Overall, the HPS-MPS-MiSeq assay displayed slightly higher overall read counts for both 
homozygote and heterozygote genotypes per variant compared to HPS-MPS-ION (HPS-MPS-
MiSeq: average 1039 reads homozygous, average 570 reads heterozygous calls, HPS-MPS-ION: 
average 750 reads homozygous, average 444 read counts heterozygous calls per variant). However, 
HPS-MPS-ION showed a more balanced profile with read counts more evenly distributed across 
the different amplicons. Notably, for HPS-MPS-MiSeq, DNA variants rs1426654 (SLC24A5 
amplicon) and rs1545397 (OCA2 amplicon) displayed a much lower read count compared to the 
other DNA variants with less than 100 reads on average at 500 pg DNA input. The range in read 
counts at 500 pg DNA input for HPS-MPS-MiSeq was 14-4490 homozygous read counts, and 2-
1771 heterozygous read counts using genotypes from a total of 16 profiles (8 samples in duplicate). 
For the HPS-MPS-ION this was 199-1590 homozygous read counts, and 176-1208 heterozygous 
read counts. Additional runs and further optimization of sample input for pooled library 
preparation, PCR cycle number, and/or primer input concentrations of the low coverage loci may 
correct the imbalances in amplicon amplification observed here at this 500 pg DNA input level. 
 
Simulated casework 
Nine simulated (mock) casework samples from six different individuals were made in 
duplicate from blood, semen, saliva, hair, and touch DNA sources and analyzed with the HPS-
MPS-MiSeq and HPS-MPS-ION assays. The performance of both HPS-MPS assays, on the eight 
single source casework samples, including their concentration, are shown in Supplementary Table 
6 (Appendix F). Both assays performed well analyzing samples with DNA inputs over 100 pg; in 
agreement with results from the sensitivity testing. The mock casework samples from saliva, dried 
and degraded saliva, semen, vaginal swab, hair, and dried blood samples, with DNA input ranging 
from 121 to 6890 pg, generated complete and correct 41-SNP HPS profiles (in comparison to 
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reference profiles generated by CE typing) with both MPS assays. Incorrect results due to allele 
drop out/in, were only seen for the two touch DNA samples analyzed, likely because of low level 
input DNA (~1 pg and 18 pg, respectively). The touch DNA samples prepared for this validation 
set were obtained from physical fingerprints swabbed from a glass slide immediately (fresh), and 
after 24 hours exposure on a bench top. The freshly prepared touch DNA sample (~ 1 pg DNA) 
showed incorrect results at 16 (39%) of the 41 HPS SNPs with the HPS-MPS-MiSeq assay and 19 
(46%) SNPs with the HPS-MPS-ION assay, hence both assays had similar problems with this 
sample. The aged touch DNA sample (~ 18 pg DNA) revealed incorrect results for 6 (15%) of the 
41 HPS SNPs with the HPS-MPS-MiSeq and for one SNP (2%) with the HPS-MPS-ION. The 
performance difference of both assays between fresh and aged touch DNA is likely explained by 
differences in DNA input amount collected from the fingerprint swab, rather than the time between 
touch and trace collection. Notably, both touch-DNA samples had input amounts well below the 
sensitivity threshold established for both assays, in contrast to all other mock casework samples 
used that were near or above the sensitivity threshold. The HPS-MPS-MiSeq assay displayed 
accurate genotypes (based on HP & HPS CE typing comparison) in the range between 100 pg and 
250 pg DNA input for these mock case samples. This finding lends support to the idea that the 
singular duplicate sample in the sensitivity testing that showed dropouts at 100 pg input DNA may 
represent an outlier, and that the true sensitivity of the HPS-MPS-MiSeq assay may be closer to 
100 pg (therefore matching the sensitivity of HPS-MPS-ION) rather than the 250 pg indicated by 
sensitivity testing. Overall, both HPS MPS assays were able to generate complete and accurate 
HIrisPlex-S results from all types of simulated casework scenarios tested, except from touched 
object samples with minute input DNA amounts that were well below the estimated sensitivity 
threshold of the assays.  
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Mixture sample testing and deconvolution tool 
Mixture deconvolution is an active area of research [33] and several commercial tools [34, 
35] have been developed to assist in mixture interpretation of forensic STR profiles. However, 
mixture separation tools for SNPs are currently lacking. As previously stated, it is very difficult to 
separate out mixtures when using CE-based SNP genotyping methods. Next to the increased 
multiplex capacity, this provided the other motivation to develop MPS-based SNP assays, which 
allows sequencing of the nucleotides surrounding the DNA variant and provides read count 
information per allele. Counting sequencing reads allows a quantitative assessment with 
advantages for mixture deconvolution, whereas peak height estimation using relative florescence 
units (RFU) generated from CE-based analysis is semi-quantitative. Although there are several 
criteria to detect a possible mixture, in particular, unusual read balances, at present there are no 
guidelines that can indicate a mixture using autosomal SNP data generated from MPS methods. 
Therefore, in order to test the mixture performance of both HPS-MPS assays in conjunction with 
the HPS-MPS analysis pipeline, a mixture calculator tool was designed to assist with 2-person 
mixture deconvolution designed specifically for the MPS platform and MPS assay used.  This tool 
can be found in Supplementary Table 2 (Appendix B). The mixture tool works on the basis of the 
minimum read count thresholds as described in Supplementary Table 5 (Appendix E), and a ratio 
input calculation that separates read counts according to a Major: Minor ratio, within a 2-person 
mixture, all based upon the premise of an STR profile being available prior to the use of these FDP 
tools (i.e following common casework practice). By designing the mixture deconvolution tool 
around the input of a Major: Minor profile from STR data, the knowledge gleaned from 
heterozygote read counts per variant, and read counts for several 2-person mixture scenarios are 
generated within the tool for the user to decide which scenario their sample most closely resembles. 
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Also built into the tool is a range at which heterozygotes are called using read count information 
from the 500 pg input, as described above section 3.2. For example, not all heterozygote alleles 
are sequenced in a 50:50 ratio for single source samples; with some loci displaying a higher read 
count for a specific allele at a particular locus (see Supplementary Table 7 [Appendix G] for more 
details). Although this is a rather simple tool, it provides the basis for future tools to be more 
automated by using this process/guide as a starting point. A caveat to this tool in its current version 
is that not all heterozygotes were present in the available dataset. Therefore some HPS DNA 
variants such as rs1805006 MC1R, rs1805007 MC1R, rs201326893 MC1R, rs1110400 MC1R, 
rs12821256 KITLG, rs12203592 IRF4, rs2378249 PIGU, rs2238289 HERC2, rs6119471 ASIP, 
rs6059655 RALY, and rs3212355 MC1R do not have their heterozygote read count information 
incorporated into this tool at present. To overcome this data deficit, a conservative 45:55 standard 
deviation range is currently applied for these HPS DNA variants. Reference and alternate read 
counts at each site are compared to the various scenarios presented in the tool to determine the 
genotype profiles for the major and minor contributors to the sample and a ranking of the best 
scenario is generated with a value and a color code from green to red.  The more green together 
with the lower the number, the more probable the scenario.  
To assess the performance of this tool, mixture samples were sequenced with both HPS-
MPS assays at mixture ratios of 1:1, 1:2, 1:5, and 1:10 (x2) for two separate sets of individuals (2 
sets of 2 individual mixtures), to give 10 mixture types that were run in duplicate, total N = 20 per 
each MPS assay) with varying phenotypes and genotypes (see Supplementary Table 1 [Appendix 
A] for more specific details). A human evaluator was tasked with using the tool to infer the profiles 
of the contributors on a variant-by-variant basis. Other than knowledge on the ratios for each of 
the test mixtures, the human evaluator did not have the genotypes of the two individuals used in 
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the mixtures to compare, until the end of their assessment of the separated genotypes. All mixture 
contributors were quantified as being above the sensitivity thresholds for DNA input, therefore the 
chance of dropout was not accounted for in this assessment. Most scenarios (i.e. both major and 
minor profiles homozygous for reference allele, or major homozygote and minor heterozygote) 
and therefore the genotypes of the two individuals, could be separated by utilizing this tool. As the 
assessment was done on a variant-by-variant basis, these results are presented in Supplementary 
Table 8 (Appendix H). Overall, 28 of the 41 HPS SNPs could be fully separated into two individual 
profiles in 100% of samples across the 40 samples analyzed with both MPS assays. In the case of 
the other 13 variants, there were three DNA variants that resulted in inconsistent mixture 
separations (more than 20 errors or over half of the samples tested) leading to incorrect genotypes 
per person at rs1805005 MC1R, rs4959270 EXOC2, and rs2402130 SLC24A4. Incorrect genotype 
calls here signifies that he most probable scenario did not always reflect the actual prepared DNA 
scenario for these variants. This could be due to the fact that i) the pre-made sample did not actually 
reflect the true ratio for that variant (i.e. sample DNA was not exactly 1:10 with regards DNA 
input) or ii) that several scenarios may overlap when taking standard deviations of read count into 
account. The standard deviation for this tool was calculated based on the allelic imbalance 
observed per variant in its heterozygous state where there can be 5-15% read count variation in 
allele sequencing coverage (i.e. genotype GA called with 100 sequence depth, G allele called in 
the sequence 40 times, A allele called 60 times make it a 40:60 ratio, so for a 50:50 ratio for that 
heterozygote, a 10% read count deviation applies). Caution should be taken with these SNPs when 
utilizing this tool to access 2-person mixture profiles for input into the HIrisPlex-S prediction 
webtool. The final 10 variants showed a lower level of error in approximately 10-19 cases or 25-
50% of total samples tested. Lastly, it is highly recommended to use the mixture tool as a guide 
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but still perform a manual check on how close the second and third scenarios are as some read 
counts may fall between two scenarios due to read count standard deviation. Additional genotyping 
of more individuals at these erroneous sites may provide a clearer heterozygote read count range 
to help refine the standard deviation generated for these sites for future developments of this 
deconvolution tool. It was also worth noting that the mixture samples prepared in 1:1 ratios were 
unable to be called using the tool alone. We recommend that in situations in which genotype read 
counts vastly differ from any given prediction scenario, or when ratio information still does not 
provide assistance, that a genome viewer such as Integrative Genomics Viewer (IGV) [36] is used 
to align and visualize the physical DNA strands to help assist in the resolution of the mixture data.  
As an examination of an additional type of scenario that could be encountered during 
mixture interpretation of a sample, we tested the performance of the mixture tool without mixture 
ratio knowledge (i.e. no STR profile information to show minor:major ratio), using a simulated 
casework sample from mixed semen and vaginal material. The vaginal swab of unknown DNA 
concentration was dipped into semen aliquot of unknown concentration, and this sample was 
extracted for DNA and run through the HPS-MPS pipeline and mixture tool designed for both 
HPS-MPS assays. In order to successfully process this sample, the minor contributor ratio was 
adjusted to see if an appropriate scenario read count could be matched. Deconvolution of this 
mixture was possible for both HPS-MPS assays without prior ratio information once a 0.4 minor 
contributor ratio was input (1:2.5 ratio). It is worth noting that human examiner interpretation is 
still needed when making the final genotype decision, especially with the troublesome variants 
noted above. However, the use of this tool greatly aided mixture deconvolution on a variant-by-
variant basis.  In some scenarios it may not be possible to split the profile and therefore genotype 
options (i.e. report minor profile as being GA or GG with major being GG or GA) if separation is 
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not easily possible at that variant. To provide a simple visualization of how to assess a sample in 
terms of source (single or 2-person mixture) and read count threshold (clean calls or potential for 
allele drop out), a flowchart (Figure 6 [Figure 4 in manuscript]) has been designed that indicates 
what tools and tables to use to better understand how to deal with an unknown sample using both 
sequencing assays and systems. A more in-depth guide can also be found in Supplementary 
Material 1 (Appendix K). 
 
Specificity and degradation testing 
Five animal species were tested with the HPS-MPS-MiSeq and the HPS-MPS-ION assays. 
Samples included cat, dog, pig, mouse, and chimp (at DNA inputs of 1ng). The number of 
sequencing reads generated for the five species with both assays is shown in Supplementary Table 
9 (Appendix I).  Using the HPS-MPS-MiSeq assay, 31 (76 %) of the 41 DNA variants revealed 
sequencing reads in the cat, 34 (83 %) in pig, 40 (98 %) in the mouse, and 2 (1 %) in the dog, 
whereas the chimp produced a genotype profile of 39 (95 %) HIrisPlex DNA (as would be 
expected). With the HPS-MPS-ION assay, 21 (51 %) DNA variants yielded sequencing results in 
the cat, 20 (49 %) in the pig, 31 (76 %) in the mouse, 28 (68 %) in the dog, the chimp produced a 
full profile of all 41 HIrisPlex DNA variants. Amplification of particular HPS DNA variants can 
be explained by conserved genomic regions in these species; however, in such cases, the read 
counts obtained from non-human samples were typically much lower (> 100 times lower at some 
sites) and more fragmented (as seen using IGV software) than sequences typically generated from 
a human DNA sample at 1ng DNA input. On average, read count comparisons of the species to 
mean read count of the 500 pg human DNA input samples (from the coverage consistency section 
above) shows that the species gave a genotype call range from 49% - 98% (discounting chimp 
comparisons, which showed which showed much lower read counts of about 100 times lower). 
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Overall, the non-human species average read count was much lower than that expected for a 1 ng 
human DNA input if it were human DNA input. For HPS-MPS-MiSeq, the cat gave 2 times less 
in read count sample average, while the pig and the mouse gave 4 times less. For HPS-MPS-ION, 
the cat gave 100 times less in read count sample average, while the pig (10 times), the mouse (30 
times) and the dog gave 8 times less. These observations coupled with the partial profiles generated 
may serve as a tool to help distinguish human and non-human samples when evaluating an 
unknown crime scene DNA sample. However, since FDP would be typically performed on crime 
scene DNA samples after STR profiling, human DNA is already detected in each case.  
To prepare samples that would test the effect of DNA degradation on the performance of 
the in-house designed HPS-MPS-MiSeq assay, aliquots of a single source 500 pg DNA input 
sample was subjected to Ultraviolet (UV) radiation for 0 seconds, 5 minutes, 10 minutes, and 20 
minutes. Even after 10 minutes of UV light exposure, a complete 41-SNP HPS profile was 
achieved with an average coverage of 2040 reads. After 20 minutes of UV light exposure 5 SNPs: 
rs28777 SLC45A2, rs4959270 EXOC2, rs12896399 SLC24A4, rs1426654 SLC24A5, and 
rs3212355 MC1R displayed drop out due to suspected degradation. These results indicate the 
robustness of HPS-MPS-MiSeq assay to cope with environmental degradation. Degradation 
information with read counts is given in Supplementary Table 10 (Appendix J). For HPS-MPS-
ION, degradation testing was not performed on these artificially degraded DNA samples. However, 
preliminary evidence of this assay’s ability to deal with naturally degraded DNA comes from the 
analysis of a series of DNA samples extracted from bones that spent approximately 1 to 78 years 
in soil, where HPS-MPS-ION efficiency was found to be comparable to that of the GlobalFiler 
PCR amplification kit on the same samples Although, it should be noted that the maximal DNA 
amount used to analyze STRs was 15 µl whereas only 6 µl was used for HPS-MPS-ION which 
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made a significant difference in the weak samples. Full HPS profiles were obtained from as little 
as 50 pg of DNA with 200 reads coverage threshold. However, performance of three SNPs: 
rs1545397 and rs1470608 in OCA2 and rs10756819 in BNC2 was slightly weaker compared to 
other markers (W. Branicki, personal communication). 
 
Concordance testing 
In all, five partner laboratories, with varying MPS experience and complementary to US 
and Rotterdam, were involved in the concordance testing of the two HPS-MPS assays, 3 for HPS-
MPS-ION and 2 for HPS-MPS-MiSeq. During the initial phase of the concordance testing it 
became evident that there was a need for guidelines for HPS-MPS data interpretation with regards 
read count thresholds and data assessment for single source versus mixture interpretation. 
Therefore, such interpretation guidelines were designed to assist the HPS-MPS assay users in 
genotype calling and mixture separation using the output from the HPS-MPS analysis pipeline. 
Concordance testers were asked to generate data on unknown samples (N=16) that ranged in 
concentration from 6 pg to 25.4 ng DNA input, thus including samples that were below the DNA 
input thresholds established in the sensitivity testing of these two assays (see Supplementary Table 
3 [Appendix C] for more details). They were also tasked with running the raw FastQ sequence 
files, output by the sequencers, through the HPS-MPS analysis pipeline to generate the necessary 
genotype calls and read count information files (for more information on the pipeline and what is 
generated please see Supplementary Material 1 [Appendix K]) using their respective 
machines/assays. Lastly, concordance testers were asked to use the threshold and mixture tool they 
were provided with (Supplementary Table 2 [Appendix B]) to generate each samples genotype 
interpretation. Figure 6 (Figure 4 in manuscript) below provides an outline of how best to deal 
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with single/mixture sources, and was the guideline given to the concordance sites. Concordance 
testers used this approach for each of their sample result files, and summarized their interpretation 
results in a single file where it was compared with the main US and Rotterdam development 
laboratory results.  
 
Figure 6 (Figure 4 in manuscript) Interpretation flowchart for the HIrisPlex-S MPS pipeline  
 
The results of the concordance study can be found in Supplementary Table 3 (Appendix 
C), where the source type and concentration of the sample are given, together with each site’s 
correct interpretation calls (number and %) for that sample (Supplementary Table 2 [Appendix 
B]). This table displays % agreement between the assay developing site and the respective 
concordance sites (US for the HPS-MPS-MiSeq assay versus the two MiSeq concordance sites, 
and Rotterdam for the HPS-MPS-ION assay versus the three Ion Torrent concordance sites).  The 
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criteria used to report the final genotype per variant according to the minimum thresholds (per 
assay/machine) and final genotype calls scenario (including those used in mixture scenario 
separations) are described in Supplementary Table 2 (Appendix B). The top portion of the result 
table reflects only the correct (number and %) genotype calls generated by the scenarios (single vs 
mixed) but does not take into account the minimum threshold needed to call a variants genotype 
with confidence. As can be seen from the top portion of the table, HPS-MPS-MiSeq generated the 
HPS SNP genotypes for each locus, ranging in genotype success from 49% - 100% (> 100 pg DNA 
input average genotype success is 84%) compared to 56% -100% (> 100 pg DNA input average 
genotype success is 92%) for HPS-MPS-ION. The bottom portion of the table shows that HPS-
MPS-MiSeq did not perform as well as HPS-MPS-ION when factoring in the minimum read count 
threshold (which can also be found in Supplementary Table 5 (Appendix E) under the < 50 pg 
level DNA input column). This threshold is required to pass the genotyping call confidence criteria 
and rules of interpretation proposed by this study and as described in Supplementary Material 2 
(Appendix L) guide. The HPS-MPS-MiSeq concordance result interpretation assessment ranged 
from 12%-85% result agreement (>100 pg DNA input average interpretation success is 33%) with 
the reference data obtained at the US assay developing site, while for HPS-MPS-ION it ranged 
from 61% - 100% result agreement (> 100 pg DNA input average interpretation success is 88%) 
with the reference data generated at the Rotterdam assay developing site. Note that, ‘0%’ for some 
samples indicates that no data passed the threshold minimum read count for that sample at that 
laboratory during the interpretation assessment.  
Overall, the HPS-MPS-ION assay performed well in this concordance testing in both 
assessments with on average 89% agreement with the reference data. The HPS-MPS-MiSeq assay 
underperformed with on average reference data agreement from both assessments only being on 
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average 58%. Due to the in-house design and the multiple steps needed in the library preparation 
of the MiSeq assay, it is possible that primer degradation occurred (especially with regards the 
small indexing primers needed for an integral step in the process of the MiSeq library preparation) 
that affected the significant decrease in read counts generated at the MiSeq concordance sites. 
Overall, average read counts for the same 100 pg DNA input sample (9947A standard control) run 
by the reference US site (which has vast experience in running this particular in-house design) 
were approximately double (1185) the average read counts of the two concordance sites (859 and 
577 respectively). This lends support to the possibility of HPS-MPS-MiSeq primer and/or sample 
degradation during material shipment to the concordance testers.  
2.5 Conclusions 
This study introduced and forensically validated MPS assays for the HIrisPlex-S system for 
eye, hair, and skin color prediction from DNA for the two MPS platforms commonly used in 
forensic genetics. We demonstrate that both HPS-MPS assays perform reasonably well on the 
respective MPS platforms they were developed for. The better performance of the HPS-MPS-ION 
assay may be explained by the use of the commercial AmpliSeq design compared to an in-house 
design of the HPS-MPS-MiSeq assay, which may be overcome in the future by applying the 
AmpliSeq design to MiSeq.  Although, both HPS-MPS assays appeared less sensitive than the 
previously reported two SNaPshot assays of the HIrisPlex-S system, due to the fact that the MPS 
assays simultaneously analyze all 41 DNA variants, less total DNA is needed. Moreover, the HPS-
MPS assays provide advantages in mixture interpretation compared to the previous SNaPshot 
assays. The semi-automated HPS-MPS analysis pipeline and the HPS-MPS mixture analysis tool 
introduced here together with the HPS-MPS assays will benefit future application of HPS-MPS 
analysis. We envision the MPS implementation of the HIrisPlex-S system for eye, hair and skin 
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color prediction from DNA described here, to be the starting point for expanding MPS-based 
forensic DNA phenotyping. This expansion is expected to include the addition of SNPs predictive 
for more externally visible traits, as well as SNPs suitable for bio-geographic ancestry inference, 
provided such predictive SNPs are identified and suitable statistical prediction models are 
developed. 
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CHAPTER 3. PROTEOMIC ANALYSIS OF HAIR 
3.1 Introduction 
Proteomics incorporates biological and chemical processes into one effective technology for 
the identification and quantitation of proteins present in a sample [1, 2]. These detected proteins 
have the potential to provide DNA sequence information (with particular variant genotypes) 
obtained through the detection of amino acid changes [3]. These amino acid changes can ultimately 
be used to identify an individual via comparable profiling, i.e. by matching the unknown biological 
sample to either a known individual/suspect or potential database match [4]. For this particular 
research, we were interested in detecting proteins obtained from hair samples due to the ease at 
which hair may be shed and therefore available at a crime scene. To note, a hair bulb is not required 
for this laboratory approach, approximately one inch of the hair shaft will generate enough protein 
material to see potential amino acid changes. Due to the presence of core proteins found within 
hair follicles [5] (mainly the Keratin class of structural proteins), we focused on a set of 233 
candidate variants commonly found in hair follicles. These variants are termed Genetically Variant 
Peptides (GVPs) and they have the potential to be classified as a type of identity marker, if assessed 
using quality control metrics such as independence and Hardy Weinberg Equilibria, and a suitable 
population frequency database were available. Current concepts and methods in forensic science 
are centered around the ability to identify humans from DNA. However, when DNA extracted 
from a sample is too degraded or too low in concentration, proteomic methods such as the one 
described above may be the solution for identification in these difficult scenarios. Due to this, it 
was necessary to assess the 233 candidate GVPs using population genetics approaches to identify 
a robust set of SNPs that may be best suited for identification purposes from hair shaft material. 
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3.2 Materials and Methods 
Hair Sample Collection and Subset Selection Criteria 
 Individuals that contributed towards this study (providing saliva and hair samples amongst 
other questionnaire data) were collected in compliance with IRB#1409306349 and included 
informed consent for all participating individuals. Each individual was assigned a randomized 
study ID number and 5ml of saliva was collected. Each participant also filled out a questionnaire 
containing numerous questions about phenotypic characteristics (ie. hair type: straight, wavy, curly) 
and familial heritage along with having three hairs removed from the back of their head and placed 
in a tube containing RNAlaterTM solution (InvitrogenTM, Carlsbad, CA).  
 Saliva samples from these individuals were sequenced at the University of Chicago 
Genomics Center using the Muti-Ethnic Genotyping Array (MEGA) by Illumina (Illumina Inc.). 
Approximately 1.7 million SNPs were identified for each sample and computationally processed 
in GenomeStudio Software (Illumina Inc.). The SNPs were then exported into PLINK [6] format 
for quality control (QC) procedures to be performed. The QC procedures include filtering for 
minor allele frequency, SNP genotyping efficiency, individual genotyping efficiency, relatedness, 
sex discrepancies, and Hardy-Weinberg Equilibrium. Individuals or samples not passing these QC 
protocols and thresholds were excluded from the dataset. After all the stringent QC metrics were 
performed, the sample dataset consisted of approximately 3,300 individuals, termed the Walsh Lab 
database, and were represented by approximately 330,000 variants for the next analyses.  
 The final set of hair samples chosen (N = 99) from the 3,300 set of individuals were 
selected for proteomic analysis based on a principle component analysis (PCA) [7] to ensure 
there was a broad distribution of populations provided for analyses. For this PCA plot, 
individuals were plotted along with 2,504 individuals from phase 3 of the 1,000 Genomes Project 
[8], and 940 individuals from Human Genome Diversity Project (HGDP) [9] which represented a 
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total of 78 populations. The 1,000 Genomes Project and HGDP contains individuals with known 
population information and were therefore used as a reference set in the PCA plot to view 
genetic distances between population groups, and therefore between individuals, allowing for the 
visualization of the population distribution of these datasets. This also allowed us to view 
important within population variation information on the individuals chosen for proteomic 
analysis (ie. Northern vs. Southern Europeans).  
 
Hair Sample Preparation for Proteomic Analysis 
 After the 99 individuals were selected from the PCA plot, hair samples were prepared and 
sent to collaborators at the University of California Davis. For this, one hair from each sample 
collection tube was removed using sterile tweezers, and the root of the hair was detached (with 
sterile medical scissors) and placed back into the original sample tube containing RNAlaterTM 
solution (InvitrogenTM, Carlsbad, CA). The remaining hair shaft was placed into a new 1.5 mL 
microcentrifuge tube, labeled with the corresponding sample number, and approximately 1000 µl 
of deionized water was added to completely cover and submerge the hair. Each hair was between 
2-4 cm in length to ensure a successful amount of protein would be detected during proteomic 
analysis. The proteomic analysis of the 99 hair shaft samples was completed in collaboration with 
faculty and students from Glendon Parker’s laboratory at the University of California Davis 
according to methods discussed in research published by Milan et al [3]. Please see this paper for 






Population Genetics Analysis on 233 Candidate GVP Set 
 Population genetics statistics were generated using data from the five main regions of the 
1000 Genomes Project: Europe, Africa, America, South Asia, and East Asia for each of the 
candidate variants. All population genetics statistics (i.e. HWE, LD, FREQ) were generated using 
PLINK [6]. PLINK is an open-source whole genome association analysis toolset that utilizes 
computational command line to efficiently compute large-scale analyses of genotype/phenotype 
data. To generate the minor allele frequency values for each SNP for each region, the --freq 
command was used. Hardy-Weinberg equilibrium values for each region were generated using the 
--hardy command. Finally, linkage disequilibrium r2 values for the entire SNP set were generated 
using the --r2 command. In addition, to identify potential ancestry informative markers (AIMs) 
within the total set of 233 variants, Fst values were calculated in a pairwise fashion for the five 
main regions using the --fst command [6]. 
 
Assessment of Proteomic Analysis Method for Inferred Genotyping 
The hairs were digested and analyzed using methods developed by collaborators at the 
University of California Davis. 233 SNPs across 127 genes were chosen as potential candidate 
markers for their possible effect on hair structure. Out of the 99 total hair samples sent to the 
University of California Davis, only 66 have been fully analyzed due to the extensive time it 
takes to process the samples. Our collaborators intend to send results for the remaining 33 
samples when they are finished being processed.  A description of the 99 total samples used for 
proteomic analysis can be seen in Appendix M. 
For the proteomic results for the 66 analyzed hair samples, GVPs that were detected were 
assigned a value of “1” at each specific SNP allele for each gene. Non-synonymous SNP alleles, 
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and therefore genotypes, were inferred for each sample from this GVP detection notation. For 
example, if a GVP was detected at rs1234 allele A and rs1234 allele G, the inferred genotype for 
the individual would be heterozygous for GA at rs1234. However, if a GVP was only detected 
at rs1234 allele G, then the inferred genotype would be homozygous GG instead.  
To assess the accuracy of the Liquid Chromatography tandem Mass Spectrometry (LC/MS-
MS) proteomic analysis method, it was necessary to compare the inferred genotypes to the actual 
genotypes of each variant for the subset of individuals used. Genotypic data for the 66-sample 
set was extracted from SNPs included in the MEGA array. The total set of 233 SNPs used in the 
proteomic analysis was crossed referenced with the SNPs included in the MEGA array and a 
total of 114 SNPs overlapped. The 114 SNPs were then assessed based on a GVP detection 
threshold in order to be determined useful in measuring the accuracy of the laboratory proteomics 
method and therefore generating correct genotype information. For this threshold, SNPs had to 
show GVP detection rates of at least 90%. Therefore, if a GVP was not detected in >10% of 
samples, the SNP was not included in the assessment. Based on of these detection thresholds, a 
final set of 32 SNPs were used for further accuracy analyses. 
 
Hair Structure Correlation Assessment 
In addition to rating the GVPs success from a proteomics perspective for identity and/or 
ancestry inference, due to our phenotyping research, we also attempted to check if one of these 
GVP variants may be a potential candidate SNP for hair structure prediction. To do this, it was 
necessary to assess the correlation and its significance between an individual’s questionnaire-based 
hair phenotype (straight, wavy, and curly) and genotype for these 114 variants with reliable 
genotypes (from the MEGA SNP array). For the first correlation assessment, the previously 
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mentioned proteomic sample set of 66 individuals and their genotypic data was used. For the 
second correlation assessment, a European-only dataset from the Walsh lab database was used for 
greater power. The assessments directly focused on the association between hair phenotype and 
genotype while controlling for the population/ancestry, sex, and age of the individuals. 
Hair structure phenotype information for all samples involved in both correlation 
assessments was obtained through the previously mentioned questionnaire filled out by all 
participants. During the correlation assessments, the phenotypes were coded on a continuous scale 
of 1, 2, and 3, representing straight, wavy and curly, respectively. After this assessment, a binary 
correlation was then performed for each hair structure type, by re-coding each phenotype as a 1 or 
0, depending on the phenotype in question. For example, during the correlation assessment for 
curly hair, all individuals with curly hair phenotype were re-coded as “1”, while the remaining 
individuals with wavy or straight hair were re-coded as “0.” This pattern was followed for wavy 
and straight hair correlation assessments.  
Genotypic data was re-coded in both correlation assessments as 0, 1, and 2 (ex. homozygote 
for allele A, heterozygote, homozygote for allele B) per SNP. Age and sex of each sample in both 
correlation assessments was also extracted from questionnaire data received during the Walsh lab 
study. Age of each individual did not need recoding, as it is already numerical, however; the sex 
of each individual was recoded as 1 for male and 2 for female for both correlation assessments. 
Ancestry correction was used in the first correlation assessment to group samples into five main 
populations: African, European, Asian, Admixed, and Middle Eastern where they were recoded as 
1, 2, 3, 4, and 5 for each individual respectively. For the second correlation, European individuals 
were selected from the 3,300 database set, leaving 1,821 European individuals to assess.  
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Each correlation assessment was performed using the R program [10] and the command “pcor.test” 
from the ppcor package [11]. The r2 correlation coefficient and its significance (p-value) of the 
phenotype: genotype correlation was generated and output per SNP. The covariates for this 
analysis were age, sex, and ancestry. A Bonferroni correction value was also generated using the 
R command “p.adjust” and “BH” was used as the method. 
3.3 Results and Discussion 
Assessment of Proteomic Method for Inferring Genotypes from GVP Information 
A result file was sent from our collaborators at UC Davis. It included information on gene 
and SNP name and their corresponding SAAP and peptide sequences. They coded the data based 
on the detection of the GVP according to their method metrics. As previously stated, their 
proteomic method and protocol can be seen in research publish by Milan et al. [3]. Upon receiving 
these proteomic analysis results, it was necessary to evaluate the accuracy of the GVP detection 
and genotype inference method by comparing to genotypes that were generated from the MEGA 
SNP array (N=114 overlapping). The current proteomic method was unable to detect GVPs for 
some of the SNPs. Therefore, in order to calculate the accuracy of the method, it was important to 
identify the SNPs with the highest rate of detection first. Any SNPs that GVPs were not detected 
in >10% of the sample set (N=66) were eliminated from the list. This list of SNPs was then 
separated based on SNPs with known genotypic information and SNPs without this genotype 
confirmation. Finally, the remaining markers were assessed for population heterozygosity and 
statistical independence by computing Hardy-Weinberg equilibrium and linkage disequilibrium 
(LD) statistics (discussed in the next section). The final set of markers passed these metrics (in 
HWE, not in LD) and was composed of 21 SNPs with genotypic confirmed data and 11 SNPs 
without genotypic confirmed data. The final set of markers and their GVP missingness (% of GVPs 
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not detected) and genotype accuracy calculations can be seen in Table 2 below. The set of 21 SNPs 
will now be referred to as GVP21 and the complete set of all proteomically detected markers 
regardless of genotypic data (21 SNPs plus 11 SNPs) will be referred to as GVPComplete. 
Genotype frequencies for GVPComplete for the 66 sample dataset can be seen in Appendix N to 
give a general idea of overall genotype distributions.  
Table 2 Genotype Accuracy and GVP Missingness for GVPComplete. The SNPs highlighted in orange are included 
in GVP21. The remaining SNPs are the 11 SNPs without genotypic confirmed data. 
 
 
CHROM POS SNP REF ALT % GVP Missingness Genotype % Accuracy
1 153431406 rs41265164 G A 2% 72%
1 153520203 rs116208483 G C 0% 100%
1 153520954 rs62624468 C T 8% 89%
1 201289487 rs61818256 C T 8% 89%
6 74014637 rs28763966 C A 0% 100%
6 7581001 rs28763967 C T 0% 100%
12 52788945 rs1791634 C G 0% 98%
12 53069014 rs17678945 C A 10% 84%
14 113975768 rs10148371 G A 0% 100%
14 55609418 rs11125 A T 0% 100%
17 38859509 rs7213256 C T 2% 86%
17 39116603 rs17843021 G A 3% 83%
17 39116728 rs142154718 C T 0% 100%
17 39183254 rs62623375 C T 5% 92%
17 39593768 rs2604953 G T 9% 77%
17 39633354 rs138303882 G A 0% 97%
17 39635733 rs743686 A G 0% 92%
17 39913771 rs41283425 C T 0% 92%
18 28605818 rs79011243 C A 3% 92%
21 31744310 rs9636845 A T 2% 86%
21 32253513 rs71321355 C T 8% 75%
17 39913771 rs143043662 C T 0% —
17 39619115 rs2071563 G A 0% —
17 39620641 rs146792525 C T 0% —
12 52788928 rs2658658 G A 9% —
12 52788945 rs1732263 C G 3% —
12 52713088 rs2857663 G A 0% —
17 39183313 rs148449559 G C 3% —
17 39156084 rs9897046 T C 6% —
17 39334241 rs62067292 G C 3% —
17 39323971 rs428371 G A 5% —
21 46117792 rs34302939 G A 8% —
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GVP21 was used to compute genotyping accuracy statistics due to the ability to compare 
the inferred genotypes from the detected GVPs to the actual genotypes (SNP array data) of the 66 
samples. Genotyping accuracy varied per SNP and ranged from 72% - 100%, with an average 
genotyping accuracy of 91%. The genotyping accuracy was lower (72% - 77%) for the SNPs that 
displayed higher levels of heterozygosity within the sample set (rs41265164, rs71321355, 
rs2604953) and higher (100%) for the SNPs that were lower in heterozygosity (rs116208483, 
rs28763966, rs28763967, rs10148371, rs11125, rs142154718). Therefore, although most 
maintained an average genotyping accuracy, the distribution of these accuracies suggests that the 
current method of GVP detection may be missing out on important genotypic data. The true 
accuracy of the inferred genotyping proteomic method was unable to be calculated for the set of 
11 additional SNPs in GVPComplete because genotypic data was unavailable. It is important to 
perform a genotyping accuracy assessment in the future to confidently include them into the 
optimal GVPComplete identity set.  
 
Probability of Identity (PID) Using an Optimal Set of Hair GVPs – GVP21 & GVPComplete 
In order to use the product rule to generate a match probability statistic for a sample, it is 
vital that the variant pass both HWE and LD assessments. Variants should be in HWE and not in 
LD with any other variant in the identity set. All SNPs in GVP21 passed Hardy-Weinberg 
equilibrium tests, however; two of the SNPs were in linkage disequilibrium with other SNPs in the 
set (rs17843021 and rs62623375). Based on this, only rs17843021 and rs62623375 were used in 
the calculations, while the SNPs that were in LD with them were not. The 11 additional SNPs in 
GVPComplete passed Hardy-Weinberg equilibrium tests, however; three of the SNPs were in 
linkage disequilibrium with other SNPs in the set (rs9897046, rs428371, and rs34302939). Once 
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again, this led to the inclusion of rs9897046, rs428371, and rs34302939 in calculations and the 
exclusion of their complementary linked SNPs.  A summary of these metrics for GVPComplete 
can be found in Table 3 below. 
 
Table 3 Hardy-Weinberg Equilibrium and Linkage Disequilibrium Assessments for GVPComplete 
     Hardy-Weinberg Equilibrium 
Linkage 
Disequilibrium 
CHROM POS SNP REF ALT AFR EUR AMER SASIA EASIA Global R2 
1 153431406 rs41265164 G A 0.2032 0.3855 0.2383 1 1   
1 153520203 rs116208483 G C 1 1 1 1 1   
1 153520954 rs62624468 C T 0.2257 1 1 1 1   
1 201289487 rs61818256 C T 1 1 1 1 1   
6 74014637 rs28763966 C A 0.2496 1 1 1 1   
6 7581001 rs28763967 C T 1 0.1141 1 1 1   
12 52788945 rs1791634 C G 0.1928 0.1455 0.3123 0.2744 0.7601   
12 53069014 rs17678945 C A 0.794 0.372 0.6466 0.2375 1   
14 113975768 rs10148371 G A 0.6436 1 1 0.1982 1   
14 55609418 rs11125 A T 1 1 1 1 1   
17 38859509 rs7213256 C T 1 1 1 1 1   
17 39116603 rs17843021 G A 0.3533 1 1 1 1 rs17843023 (0.382633) 
17 39116728 rs142154718 C T 1 0.7577 0.4618 1 1   
17 39183254 rs62623375 C T 1 0.869 0.07901 1 1 rs150218495 (0.220935) 
17 39593768 rs2604953 G T 0.876 1 1 0.1279 0.1366   
17 39633354 rs138303882 G A 1 1 1 1 1   
17 39635733 rs743686 A G 0.04065 1 0.1874 0.3118 1   
17 39913771 rs41283425 C T 0.2556 1 0.2907 0.02936 0.191   
18 28605818 rs79011243 C A 1 1 1 1 1   
21 31744310 rs9636845 A T 0.4559 1 0.027 1 1   
21 32253513 rs71321355 C T 1 0.4996 0.09218 1 1   
17 39913771 rs143043662 C T 0.4076 0.3864 0.8761 0.3555 1   
17 39619115 rs2071563 G A 0.6334 0.5838 0.2662 0.5399 0.7647   
17 39620641 rs146792525 C T 1 1 1 1 1   
12 52788928 rs2658658 G A 1 1 1 1 1   
12 52788945 rs1732263 C G 0.4842 0.8575 0.1576 0.2331 0.7637   




Table 3 continued 
17 39183313 rs148449559 G C 1 0.3927 0.314 0.1449 1   





17 39334241 rs62067292 G C 1 1 0.7421 0.08258 0.3706   











21 46117792 rs34302939 G A 0.002152 0.3573 0.1714 0.6986 1   
 
 The probability of identity (PID) was calculated for the marker sets GVP21 and 
GVPComplete in order to apply power to the current proteomic detection method. The probability 
of identity is the probability that two individuals selected at random will have an identical profile 
using the same set of variants. It is useful in SNP panel studies to determine the minimum number 
of SNPs needed for identity calling. It is easily explained as: the lower the probability of identity, 
the more variable the DNA markers. The PID of a locus is calculated as the sum of squares of the 
genotype frequencies for that SNP. The product of these values for a set of loci then provides a 
PID for the total set of markers used. The full tables of calculations can be found in Appendix O. 
The PID was calculated for each population (Africa, America, South Asia, East Asia, and Europe) 
and can be seen in Table 4 below. Each population should be treated independently in identity 
calculations to accurately represent the true power of the SNP set. 
80 
 
Table 4 Probability of Identity for all populations on GVP21 and GVPComplete 
 
The average probability of identity was 8.97 x 10-3 for GVP21 and 3.58 x 10-4 for 
GVPComplete. The probability of identity for GVPComplete will hold more power after the 11 
additional SNPs have been genotyped and checked for method accuracy. These probabilities give 
insight on the usefulness of these two marker sets for identification, but also proves that the current 
laboratory method could use improvement with regards to the detection of these GVPs. With better 
SNP detection in the proteomic analysis comes more power in the probability of identity 
calculation, which is crucial in forensic casework. In current forensic methods for human 
identification, STR kits like Identifiler (ThermoFisher Scientific) and Globalfiler (ThermoFisher 
Scientific) exhibit high probabilities of identity at 6.18 x 10-19 and 7.73 x 10-28. These kits are 
forensically stable due to their high polymorphic characteristics across all populations and set an 
exceptional standard for other human identification methods.  
Consequently, it is apparent that additional extensive research in proteomics is still required 
to obtain a stable set of forensically applicable markers exuding a strong probability of identity. 
Refining the proteomic analysis method will be the first catalyst for improving this statistic, but 
still may not reach the high standard of current forensic STR kits. If that is the case, researchers 




SNP Set Africa (n=661) America (n=347) East Asia (n=504) South Asia (n=489) Europe (n=503)
GVP21 1.14E-03 4.96E-03 1.68E-02 8.46E-03 1.34E-02
GVPComplete 2.49E-06 1.29E-04 1.23E-03 1.08E-04 3.21E-04
Probability of Identity (PID)
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Identifying Potential AIMs and Generating Metrics for the Full GVP Candidate List 
A population genetics assessment was conducted on the full set of 233 SNPs to identify 
potential ancestry informative markers (AIMs). The full set of markers, as seen in Appendix P, 
was also assessed for their ability to be used as an identity marker, if the proteomics method were 
to improve in the future. Each candidate GVP was analyzed using genotype data from the 1000 
Genomes project and assessed based on Fst values, heterozygosity, minor allele frequency, linkage 
disequilibrium, and Hardy-Weinberg equilibrium. The full list of SNPs and their allele frequencies 
for African, American, South Asian, East Asian, and European populations can be found in 
Appendix Q. These were obtained through population data from the 1000 Genomes Project and 
were generated using PLINK [6] commands. For the potential future use of these markers in 
forensic applications, it was necessary to generate an allelic frequency table. In order to apply 
statistical power to the rarity of a genetic profile, statistics such as random match probabilities or 
likelihood ratios are calculated. These statistics, and therefore the identification of an individual, 
rely on this population frequency information. If this set of markers were to be used for forensic 
human identification in the future, these allelic frequencies may be used to compute the match 
probability statistic. However, it is advisable to obtain more population datasets and individuals to 
improve the accuracy of this calculation as the 1000 Genomes project dataset only consists of 26 
global populations and within region (i.e. within Europe) frequencies do not truly represent the 
countries in this region.  
Analyses of population genetics structure have shown that continental population groups 
can be identified by examining differences in allele frequencies and measuring the degree of this 
differentiation by computing Fst values. Large Fst values correspond to large absolute allelic 
frequency differences. Therefore, calculating these values in a pairwise fashion gives insight on 
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markers that are distinguishable across populations. These distinguishable differences lead to the 
development of ancestry informative markers, which can be highly beneficial in forensic settings.  
Allelic frequencies and Fst measurements were evaluated for the total set of 233 SNPs 
using data from the 1000 Genomes Project. The markers that had allelic frequencies near fixation 
in specific populations and exhibited high Fst values (>0.2) across all populations in the pairwise 
analysis were identified as potential ancestry informative markers and can be seen in Table 5.  A 
scatterplot of these markers and their minor allele frequencies can be seen in Figure 7.  
Table 5 Minor allele frequencies and Fst values for AIMs for all populations  
  Africa America East Asia Europe South Asia 









rs2037912 0.428-0.626 0.03026 0.471 0.652 0.532 0.486 
rs9891361 0.641-0.703 0.8298 0.138 0.095 0.099 0.089 
rs3120655 0.291-0.376 0.407 0.033 0 0.001 0 
rs385055 0.348-0.430 0.466 0.033 0 0.002 0 
rs214803 0.301-0.441 0.59 0.167 0.075 0.162 0.157 
rs2634041 0.339-0.398 0.259 0.269 0.7589 0.283 0.308 





Figure 7 Ancestry Informative Markers within 233 SNP Set 
 
Based on this analysis, 7 markers were determined to help infer ancestry for two 
populations: Africa versus non-African, and East Asia versus non East-Asian. For the African 
population, 5 SNPs were identified as potential AIMs: rs2037912, rs9891361, rs3120655, 
rs385055, and rs214803. These markers are highlighted in green in the table found in Appendix P. 
The marker with the highest pairwise Fst values, or most genetic differentiation between the other 
populations, was rs9891361 with values ranging from 0.64-0.70. The most informative marker 
based on allelic frequencies was rs3120655. This SNP displayed allele frequencies near fixation 
(0) for all populations other than Africa, with an African minor allele frequency of 0.407. This 
indicates that there is a high level of heterozygosity in the African population for this SNP and 
suggests that if the allele is then present in a sample, the probability of it coming from an American, 
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East Asian, South Asian, or European is very low. For the East Asian population, 2 SNPs were 
identified as potential AIMs: rs2634041 and rs6761276. Although these markers were not as 
informative as the African markers, they both showed high levels of Fst with ranges from 0.28-
0.39, indicating that there is a high level of genetic differentiation with the other populations.  
This knowledge could be useful in a forensic setting when calculating match probability 
statistics for a casework sample. If a hair sample were found at a crime scene and this proteomic 
analysis was used to generate a genetic profile, this set of AIMs could be used to infer the 
population to which the perpetrator belongs. If a specific population is identified first, the allelic 
frequencies for that specific population can be used in an RMP or likelihood ratio calculation, 
providing a more powerful and specific statistic.  
However, if these 7 AIMs do not provide assistance in first identifying the ancestral origin 
of the individual, other SNPs in the 233 marker set could still be used for the individualization of 
the genetic profile. After removing the 7 AIMs, the 226 remaining SNPs were assessed for their 
suitability as an identity marker via linkage disequilibrium and Hardy-Weinberg equilibrium 
testing. The primary goal in human identification is to reliably distinguish unrelated individuals 
from one another, therefore SNPs that do not pass these tests, or are not independently inherited, 
should not be used in human identification. SNPs that did not pass these tests can be seen in 
Appendix P denoted with an “X”. SNPs that displayed LD with any other SNP in the set were 
completely removed as well as SNPs that did not pass HWE (<0.0002). The remaining 124 SNPs 
that passed the population genetics assessment for LD and HWE can then be used for identification. 
Using these markers in a forensic setting would require all populations and their allelic frequencies 
to be used and reported for RMP calculations. As previously stated, these SNPs and their allele 
frequencies per population can be seen in Appendix Q.  
85 
 
Hair Structure Correlation Assessment 
 A Pearson’s correlation test was performed in R to assess the association between genotype 
and hair structure phenotype for the 114 SNPs that were included in both the proteomic analysis 
and the MEGA array. During each correlation assessment, the ancestry, age, and sex of each 
individual was controlled for by assigning them as test covariates.  
 For the first correlation, genotype and phenotype data was assessed for the 66 samples used 
in the proteomic analysis. After running the correlation, there seemed to be a significant positive 
correlation (p-value <0.05, passing Bonferroni correction, and R2 correlation values >0.4) for a 
small number of SNPs, which specifically corresponded to the curly hair phenotype. However, 
these significant correlation values were later hypothesized to be due to a high rate of African 
American or Admixed individuals with curly hair within the small dataset of 66 individuals. Out 
of 66 individuals, 21 self-reported their hair type as curly. Of the 21 individuals with curly hair, 
20 were African American or Admixed. The effect of the ancestral origin of the individual on the 
hair phenotype was too strong, making it unable to be completely controlled for during the 
correlation test. 
 Therefore, the second correlation assessment was conducted to test the above hypothesis 
and to prove or disprove the significance of the SNPs found in the first correlation. To do this 
assessment, it was crucial to use a bigger sample size and isolate individuals based on their 
populations, specifically if they were European or non-European. By removing individuals with 
non-European ancestral origins from the dataset, there will be less of a population stratification 
effect. If a significance value or correlation remained after testing on a European-only sample set, 
then the SNP could be considered as associated with the curly hair phenotype. It was also important 
to increase the power of the phenotype in the second correlation test. To do this, the phenotypes 
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of straight, wavy, and curly were re-coded as 0 and 1 (depending on the phenotype of interest) 
instead of 1, 2, and 3. By doing this, the correlation test only has two phenotypic variables to assess 
(curly vs. non-curly) instead of 3 variables (straight, curly, wavy).  
 1,821 European individuals from the Walsh lab database were used to evaluate the 
candidate GVPs for their association with hair structure. Upon initial examination, one SNP 
(rs4796697) showed significant correlation with the binary association analyses of curly versus 
non-curly in a European cohort with a p-value of 0.004298. However, after further analysis, it was 
discovered that this was likely a false positive significance value due to a low minor allele 
frequency for this SNP. It is also important to note, that using questionnaire-based phenotypes can 
lead to increased background noise and false positives, so additional research on this phenotype 
(i.e. reclassification and verification using imagery or microscopy) may provide a more accurate 
correlation assessment. It would also be recommended to correct for hair color in future analyses, 
as pigment has an effect on hair structure.  
 
Future Directions 
 Many significant insights were generated from this research, but there are still many areas 
for improvement and advancement. From this assessment, we have developed a set of 32 SNPs 
that could be used for assistance in identification in current forensic casework. We have also 
provided all necessary population genetics statistics for the total set of 233 SNPs for future use in 
forensics.  
 One of the first future directions of this research will be to finish genotyping the remaining 
119 SNPs that were not included in the MEGA SNP array. With this genotyping information, 
correct GVP genotyping accuracy calculations can be performed for any SNP (out of the 233 set) 
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that is detected by the proteomic method now and in the future. It would be valuable to be able to 
confidently add the additional 11 variants as part of the GVPComplete set for increased power in 
PID calculations. Another main goal for the future of this research would be to improve and 
optimize the proteomic method. Out of the 233 SNPs, only 32 were detected at a trustworthy rate 
(> 90%). By optimizing the method, the sensitivity may increase, allowing for the detection of 
more GVPs (for which all the population genetics assessments and population allele frequencies 
have already been generated for future use), and therefore the inference of additional variant 
genotypes to use for ancestry/identity inference purposes. During this assessment, it was also 
apparent that there was a lack of criteria or thresholds for the detection of SNPs and the 
trustworthiness of their GVP inferred genotypes going from the laboratory method to the analyses 
method. If genotypic data were not available, one would not be able to know if the inference was 
an informative GVP or not. This research has certainly attempted to put quality control metrics to 
the GVP to variant genotype conversion. Additional research could also be conducted to further 
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CHAPTER 4. CONCLUSIONS 
4.1 HIrisPlex-S system for eye, hair, and skin color prediction from DNA: massively parallel 
 sequencing solutions for two common forensically used platforms 
The first goal of this research was to assist in the development and validation of the 
HIrisPlex-S assay on the Illumina MiSeq and Thermo Fisher Ion Torrent sequencing platforms. 
The sequencing alignment and genotype extraction process was simplified with the development 
of the HPS-MPS pipeline. This semi-automated pipeline aligns sequences to the human genome 
(hg19) and extracts the 41 SNPs of interest for HIrisPlex-S. Through this forensic validation, the 
assay demonstrated sensitivity down to 250pg and was able to produce accurate genotypic profiles 
for most simulated casework DNA samples, including saliva (fresh and degraded), semen, vaginal 
secretion, hair, and dried blood. The only simulated casework samples that did not produce full 
and accurate genotypic profiles were the touch DNA samples, which both expectedly displayed 
very low input DNA concentrations. Based on the mixture studies, a mixture deconvolution and 
minimum read count threshold tool was developed. This tool is intended to aid users in the 
separation of mixtures and establish confidence in the genotypes called for the major and minor 
contributors within the sample. Ultimately, the results of this forensic validation, including the 
creation of both the mixture separation tool and HPS-MPS pipeline, demonstrate the robust ability 
of the HIrisPlex-S Massive Parallel genotyping system to produce successful results in a variety 
of Forensic DNA Phenotyping scenarios. Such advancements in forensic DNA analysis allow for 
future expansions of Forensic DNA Phenotyping on massive parallel sequencing platforms to 
include additional predictive phenotypic SNPs, bio-geographic ancestry informative markers, and 
to ultimately produce an all-in-one highly prediction assay. 
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4.2 Proteomic Analysis of Hair 
The second goal of this research was to evaluate a proteomic analysis method for 99 hair 
samples and optimize a marker set for future use in proteomics. Hair sample GVP data (n = 66) 
for 233 candidate markers was analyzed for overall detection and genotyping accuracy. 
Genotyping accuracy calculations were computed for SNPs that were also included in the Illumina 
MEGA SNP array, which totaled to 114 SNPs. After analyzing the GVP data based on detection 
thresholds, the total number of proteomically detected SNP GVPs was 32 (GVPComplete): 21 
with genotypic data from SNPs in the MEGA array (GVP21) and 11 without. Genotype accuracy 
calculations were computed for GVP21 and displayed an average of 91%. The probability of 
identity, or the probability that two individuals selected at random will have an identical genotype, 
was calculated for GVP21 and GVPComplete. The average probability of identity was 8.97 x 10-
3 for GVP21 and 3.58 x 10-4 for GVPComplete. With the current proteomic method, these 32 SNPs 
(GVPComplete) could be used in forensic casework to assistance in human identification. 
 A thorough population genetics assessment was also conducted on the set of 233 candidate 
SNPs to assess their ability to be used as identity markers and identify potential ancestry 
informative markers (AIMs). Based on the population genetics tests (HWE, LD, minor allele 
frequency and heterozygosity, Fst), 7 AIMs were identified to help ancestry inference for two 
populations: East Asia and Africa. Future research should be conducted to investigate the 
usefulness of these AIMs for inferring ancestry in other datasets. Also based on the population 
genetics tests, 124 SNPs were identified as having the potential for use in human identification. 
The allele frequencies of these SNPs in each population are required to compute forensic statistics, 
specifically in random match probability calculations, to apply statistical power to the genetic 
profile. If proteomic methods improve in the future, collaborators will have the necessary 




Supplementary Table 1 Full description of the samples used for the developmental validation of the HPS-MPS 



































































Supplementary Table 3 Concordance results of the HPS-MPS assay testing for both MiSeq and Ion Torrent systems. 
Boxes in grey indicate assessment performed with read count thresholds in place for interpretation of genotype calls 































Supplementary Table 4 Information on sample drop-out and % sequencing error (using counts of incorrect allele 
divided by total read count of both alleles) observed using the HPS-MPS pipeline per HPS variant per 











Supplementary Table 5 Read count thresholds per variant for both HPS-MPS-MiSeq and HPS-MPS-ION assays for 
































































Supplementary Table 6 The performance of both HPS-MPS-MiSeq and HPS-MPS-ION assays using the HPS-MPS 
pipeline on simulated casework. A tick indicates a correct call was made for the variant for that sample. An X 




Supplementary Table 7 Observed heterozygote call ratios per variant (i.e. a GA genotype with 100 read counts of 
allele G and 100 read counts of allele A would give a 50:50 heterozygote call ratio) using the HPS-MPS-MiSeq or 
the HPS-MPS-ION assay, and HPS-MPS pipeline. Only variants with a heterozygote genotype found in the 8 





























Supplementary Table 8 Mixture separation performance per variant on simulated 2-person mixture ratios using the 
Threshold & Mixture Deconvolution Tool (Supplementary Table 2). A tick represents a correct call for all samples. 
A yellow triangle represents caution at this variant as there were correct and incorrect genotype calls generated. A 




Supplementary Table 9 Results of the performance of the HPS-MPS-MiSeq and HPS-MPS-ION assays and the HPS-





Supplementary Table 10 Results of the performance of the HPS-MPS-MiSeq and HPS-MPS-ION assays and the 
HPS-MPS pipeline on UV degraded samples. A grey box indicates no read counts were observed. Degradation was 
assessed by utilizing 500pg DNA exposed to UV light for time intervals of 0, 5, 10, and 20 min, using CL-1000 





SUPPLEMENTARY MATERIAL 1 
Guide to using the threshold & mixture deconvolution tool (*two-person mixture only) 
Please consult the flowchart found in Figure 6 (Figure 4 in manuscript) for the order in which to 
use this tool. 
1. Inputting data into the tool. 
As part of the HPS-MPS pipeline, every sample has its own folder of generated data found in the 
runfolder (~/Desktop/hps/runfolder). However for a summary of the result of each sample in one 
folder, a .csv file is created and this can be found in the TableFiles folder of the hps folder. Please 
go to this location ~/Desktop/hps/TableFiles/SAMPLE_NAME.csv 
Open this .csv file with excel to view read counts of the HPS variants. Your file will look like this. 
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Copy and paste the items in the red box from the above image (in your sample csv file) into your 
Threshold & Mixture Tool below (to the highlighted blue box in the below image). 
 
Be sure to use the MiSeq version if you used the HPS-MPS-MiSeq assay. 
Be sure to use the ION version if you used the HPS-MPS-ION assay. 
 














As soon as you paste the read counts of your file into the tool, you will see green/orange cells in 
color in the yellow region of the file. For this assessment, please make sure the Minor Input Ratio 
highlighted in a green box above is set to 0 as you are not assessing mixtures at this point. 
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There is a two-step process to assess the confidence of genotypes using the threshold guidelines 
once you have pasted in the read counts at the 100 pg input level as noted above in the red box. If 
your variant passed the threshold set for your sequencer at the 100 pg level, it will highlight the 
variant in green and call it “Passed”. This genotype may be trusted as reaching the acceptable 
levels based on 100 pg sensitivity testing of the system and that variant does not need further 
assessment. 
If the variant is highlighted in orange with “Caution”, this variant must go through the second 
check of threshold. For this, you must edit the input level to 50 pg in the red box above. 
When you edit to 50, you will see colors change in the boxes. If variant passed all of the 50 pg 
DNA level sensitivity thresholds for that sequencer, then the variant will stay orange with 
“Caution”. (To note, you will also see your green cell colors go to orange, this makes sense as they 
too have already passed the 50 pg level input). Below you can see the very same example as above 




To summarize that example, all variants apart from rs28777, rs16891982, rs12821256, rs4959270, 
rs2378249, rs12896399, rs1393350, rs1126809, rs1470608, rs1545397 passed with a green 
confidence call. Those 10 variants passed with an orange caution call. This means that the user 
should use caution during interpretation as the variant did not pass the 100 pg read count level but 
did pass the 50 pg DNA input sensitivity level as measured in this study. 
If the variant did not pass the 50 pg threshold filter, the cell will turn to red and say “Failed” as 
can be seen in the below image. It is not recommended to proceed with this variant using this tool 
and the variant should be inserted as NA for the prediction of that sample. It is at the users 
discretion if they go against this recommendation. This tool is merely a guide towards threshold 





Important to note, 100 pg and 50 pg threshold level counts are set based upon the read count 
confidence range column found in Supplementary Table 5. 
 
3. Mixture Guidelines 
Once you have confirmed the variants that can be utilized for the mixture separation of the tool 
(Green (Passed) & Orange (Caution)), you may proceed with mixture separation guidelines if 
suggested by Figure 6 (Figure 4 in manuscript) flowchart. 
 
How to check if your sample may or may not be a single source (if no STR profile available) 
and steps towards genotyping calling in either single/2-pereson mixture scenarios 






For variant 40: rs3212355 (second last variant), the homozygous REF allele is highlighted as being 
Homozygous (Y under REF allele, N under ALT allele) in the blue highlighted box. That means 
that in this sample (if single source or major profile), the individual is a C/C genotype due to all 
or majority ref allele being present versus the alt allele. The definition of majority is calculated by 
only 2% of ALT allele in comparison to REF allowed present to still call a C or Ref allele a 
homozygous genotype call. If over 2% ALT allele is present it will affect homozygous call for 
majority REF allele. If this is a 2-person mixture sample, it also means that both individuals, major 
and minor, are C/C at this variant site. 
This genotype result is indicated in the genotype calls in the highlighted yellow area. 
 
EXAMPLE 2 
For variant 38: rs6059655 (fourth last variant), the homozygous ALT allele is highlighted as being 
Homozygous, that means that in this sample (if single source or major profile), the individual is a 
G/G genotype due to nearly all (majority as defined above but for ALT allele present) ALT read 
counts are G allele calls. If this is a 2-person mixture sample, it also means that both individuals, 
major and minor, are G/G at this variant site. 
This genotype result is also indicated in the genotype calls in the highlighted yellow area. 
By first doing this step, you will have generated the majority of genotypes for the single or mixture 
samples. 
EXAMPLE 3 
If both homozygous REF and ALT are N, you have two options. Either you have a single source 
profile and the Major genotype is called heterozygous in the highlighted yellow area, or there is a 
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mixture possible as the ratios are outside the boundaries of the heterozygote balance for that variant. 
This is an indication that you may not have a single source sample. 
If you suspect or know (due to STR profile) you have a 2-person mixture. The next step is to 
establish the Major:Minor ratio of the sample. This can be obtained from STR profile data where 
one can utilize peak height ratios to give an estimate, i.e. 1:10 minor to major ratio. If this is not 
available, the user can manipulate the Major: Minor until the read counts best “match” the 
scenarios provided in cells BO:CP of this tool. The user should start with the 1:10 input (value 
0.090909) and work their way up to 1:1 ratio, which is 0.5 input. 
2. How to perform genotyping calls on non-homozygous calls when you know the 
minor:major ratio due to STR profile being available in a 2-person mixture 
The most important part of the scenario guidelines is that the minor ratio has to be filled in and 
should be as accurate an estimate as possible. This value affects how the scenarios are built from 













Both the Major and Minor profile are given a row in the blue box. If ref is mentioned then that 
contributor is homozygous ref allele. If alt is mentioned, then that contributor is homozygous alt 
allele. If het is mentioned then that contributor is heterozygous at that site. 
There is a ranking of the best scenario based on read count input and minor profile input. This is 














For the section highlighted in the black box above, the more green the scenario, with a number 
closer to 0, is the most optimal scenario in this case (IF and only IF the homozygous check is N 







SUPPLEMENTARY MATERIAL 2 
 
Guide to using the HPS-MPS pipeline 
STEP 1: Setting up Docker 
This pipeline can be used on any platform once the docker container (virtual machine) has been 




You will see install options for Mac, Windows and Linux. 
Mac – https://docs.docker.com/docker-for-mac/install/ 
Windows – https://docs.docker.com/docker-for-windows/install/ 
Linux (Ubuntu) - https://docs.docker.com/install/linux/docker-ce/ubuntu/#install-docker-ce 
 
There are particular systems requirements for these installs. If you are having trouble installing the 
Windows software, please go to this link to install the docker toolbox (supports more Windows 
operating systems). 
https://docs.docker.com/toolbox/toolbox_install_windows/ 
All links show you how to install and how to check you have installed correctly but doing a dummy 
run of  




Once you have docker installed and up and running. You will need to adjust the memory dedicated 
to the virtual machine so that the processes required to successfully run the hps-mps pipeline will 















Please increase the memory to at least 16gb if possible. Increasing CPU’s will also shorten run 
time but that is up to the user. 





Change default vm settings 
If the default Virtual Box VM does not provide enough resources to give a good experience, we 
recommend you create a new VM with at least 2 CPUs and 16GB of memory. 
• Double click the Docker Quickstart icon from your desktop and then run the following 
commands in that terminal. 
• Remove the default vm 
docker-machine rm default  
• Re-create the default vm 
o Choose the number of cpus with --virtualbox-cpu-count. For this example we'll 
use two. 
o Choose the amount of RAM: --virtualbox-memory. This is also based on the 
host hardware. However, choose at least 16GB If you can. 
o Choose the amount of disk space: --virtualbox-disk-size. It is recommended that 
this be at least 50GB since building generates a lot* of output. In this example 
we'll choose 50GB. 
o Create vm with new settings 
docker-machine create -d virtualbox --virtualbox-cpu-count=2 --virtualbox-memory=16384 --virtualbox-
disk-size=50000 default  
• Restart docker 
docker-machine stop exit  
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Then open a new Docker Quickstart Terminal. 
 
STEP 2: Setting up the hps-mps pipeline environment 
run the following command in your docker terminal 
docker run -it -v ~/Desktop:/Desktop suswalsh/hpsmps 
This will set up your environment and give it access to your desktop. Minimize this window unstill 
needed in step 4. 
 
STEP 3: Downloading folders needed for hps-mps pipeline 
1. Download the hps.zip file from here using your internet browser 
https://iu.box.com/shared/static/xs2omjmujowpxa4r2gi2kn8waiqrzbog.zip 
2. Unzip the file using whatever unzipping software you have on your computer.  
3. IT IS VERY IMPORTANT to place the ‘hps’ folder on the desktop of your computer 
(make sure it is the folder itself and not the zipped folder. Its location should be ~/Desktop/hps/ 
and not ~/Desktop/hps/hps  
 
STEP 4: Preparing for your sequence files and running the pipeline 
1. Open the docker terminal window again, and run the following commands in this terminal 
window 




If you get no errors at this stage, you have installed docker and environment correctly. If you have 
an error, please check to make sure the hps folder is on the desktop of your computer in the correct 
location (see above). 
2. Minimize this terminal window and go back to your desktop hps folder  
3. Now place your sample fastq files (any sequencer) into the hps/runfolder on your desktop, 
make sure they are unzipped (do not have .gz) before placing in hps/runfolder or 
immediately after placing in folder. Do not proceed with the pipeline with .gz files. 
4. Edit the dirlist.txt file that is in that hps/runfolder (please use software that can save the file 
as a unix file – BBedit for Mac OSX or NotePad++ for Windows) to include your sample 
names (please use names up to the first _ in the filename) as follows 
sample1-of10-of-100_S1_L001_R1_001.fastq would be titled sample1-of10-of-100, there should 




Using your sample sheet from your MiSeq or Ion Torrent run is a good way to keep track of your 
sample names going into the pipeline. **Currently the pipeline is set to running from 1-96 samples 
at once. If you include more than 96 samples, only the first 96 samples in the dirlist.csv file will 
run. 
 
5. Go back to your terminal window that you left open and paste in the following commands 








6. All results can be found in the hps folder - with the final result folder including the upload 
files for the prediction web tool. A description of every folder (within the hps folder) and what it 
contains after the pipeline has been run is described below. 
  
POST –RUN OUTPUT 
Indelcheck folder contains every samples check for the Indel variant of HPS (variant 1 in HP: 
rs796296176). There is only one indel in the HPS variants. Each sample is checked for the presence 
of this indel and a csv file is generated either if it is present or absent. 
Pipelinefiles folder contain all the necessary files for using the pipeline. There are no results 
generated in this folder. Do not delete any files or adjust files in this folder unless you are 
experienced in doing so. 
Reference folder contains the human reference files needed for alignment; in this case Hg19 is 




Result folder contains all the main result files of the run all summed up into single files. It includes 
the following files: 
 
The indelcheck file is a complete list of all samples that had the variant 1 indel. IT IS VERY 
IMPORTANT TO CHECK THIS FILE as it influences the online and onlineupload file, if a 
sample shows the presence of the indel, then you must edit both the online and onlineupload file 
for that individual to show their correct genotype i.e. 
If indel present in sample 123, go to sample 123 in the online.csv file and the onlineupload.csv file 
and change the genotype. 
With no indel that variant would say CC (online file) or 0 (onlineupload file) for that sample, the 
user will have to edit this to say CA (if hetero) or AA (if homo insertion). Also for the onlineupload 
file which is used for prediction it should be changed from 0, to 1 or 2. 
It is also best practice to edit the file found below in the TableFiles folder with this new genotype 
information (due to indelcheck). How to do this is described below. 
The online.csv file is one file with every genotype result for all (up to 96 samples) that you ran. 
The onlineupload.csv file is the online webtool file that you use to generate prediction 
probabilities for eye, hair and skin color using the website https://hirisplex.erasmusmc.nl/ 
This file needs no further editing (if the pipeline gave no errors and no indels were reported in the 





runfolder contains every file generated for each sample in each of their respective sample folder 
names. 
I.e if you name a sample Sample123, there will be a folder called Sample123 in the runfolder. In 








Scripts folder contains all the necessary scripts needed to run the pipeline. Do not delete any files 
or adjust files in this folder unless you are experienced in doing so. 
TableFiles folder generates every samples .csv file which contains variant ref and alt alleles, 
genotype calls and read counts generated from the hps-mps pipeline using the programs as 
described in Figure 3 (Figure 1 manuscript) and the manuscript materials and methods. IF YOU 
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HAVE AN INDEL IN A SAMPLE FILE, you must edit the samples genotype and read count for 
that variant 1 indel. See example on how below. Lets call the sample Sample123 
 
This shows that this sample had an indel found at our variant 1 site. The most important part are 
the number of reads for the ref * versus the +A at that site. Here it shows  
COV = 1080 
READS1 583: READS2 496. 
 
The user MUST edit the Sample123.csv file found in the TableFiles folder as being Ref.forward 
of 583 and Alt.forward of 496 for that variant with ref being C and alt being +A 
*** THESE FILES ARE USED AS INPUT THAT MUST PASS THE THRESHOLD AND 
MIXTURE TOOL RULES FOR SAMPLE INTERPRETATION  
***In order to run the pipeline from scratch on new samples, it is recommended to re-download 
the hps folder and go from STEP 4 of this guide. 
 
TROUBLESHOOTING GUIDES: 
If you experience any errors, some of the likely causes are listed below. 
1. You did not enter the correct sample name into the dirlist file (or the file must be saved as 
a unix line breaks file) 
Some of the fastq files contain no data (0 bytes) and hence that sample will not contain information 
in any of its generated files. If this happens you must delete the ‘empty’ .csv files in the TableFiles 
folder before running script 5 or it will give an error when making the final result folder files – 








































Genotype Frequencies of GVPComplete
























































































































17 39323971 rs428371 G
21 46117792 rs34302939 G
17 39156084 rs9897046 T
17 39334241 rs62067292 G
12 52713088 rs2857663 G
17 39183313 rs148449559 G
12 52788928 rs2658658 G
12 52788945 rs1732263 C
17 39619115 rs2071563 G


















































APPENDIX O  



























































































































































































































































































































Allelic Frequency Table for 233 Candidate Marker Set 
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